
Eugene J. Koay, M.D., Ph.D.
Department of GI Radiation Oncology, Division of Radiation Oncology
About Dr. Eugene J. Koay
Dr. Koay is an Associate Professor in the Department of Gastrointestinal (GI) Radiation Oncology at MD Anderson Cancer Center.
The MD Anderson Department of GI Radiation Oncology represents decades of GI cancer expertise by nine radiation oncology doctors, and a specialized team of GI radiotherapy physician assistants, nurses, physicists, therapists, and dosimetrists. We treat cancers of the stomach, liver, bile duct, pancreas, rectum, and anus. We offer many types of radiotherapy technologies including intensity modulated radiation therapy (IMRT), stereotactic body radiation therapy (SBRT), and proton therapy. These are always selected and personalized for each patient. We are constantly working to improve radiotherapy for GI cancers, and offer many clinical trials designed to make radiotherapy more effective with fewer side effects.
Dr. Koay treats all types of GI cancers. He is well-recognized for his clinical and translational research on GI cancers and their properties on diagnostic imaging, participating in national and international collaborations at the forefront of science. He has published over 140 articles, and a textbook titled An Introduction to Physical Oncology. He enjoys educating the next generation and has given lectures at multiple undergraduate, graduate, medical, health professional and resident courses. He has mentored dozens of students, residents, and fellows over the past decade, helping them achieve successful presentations, publications, and awards.
Present Title & Affiliation
Primary Appointment
Adjunct Faculty, Department of Rice Engineering and Computing Department of Bioengineering, Division of Radiation Oncology, Rice University, Houston, TX
Professor, Department of GI Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
Regular Member, Graduate School of Biosciences, Houston, TX
Dual/Joint/Adjunct Appointment
Professor, Department of GI Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
Regular Member, Graduate School of Biosciences, Houston, TX
Education & Training
Degree-Granting Education
2009 | Baylor College of Medicine, Houston, Texas, US, MD |
2008 | Rice University, Houston, US, Bioengineering (BIOE), Ph.D |
2001 | Rice University, Houston, Texas, US, Chemical Engineering, BS |
Postgraduate Training
2010-2014 | Clinical Residency, Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas |
2009-2010 | Clinical Internship, The University of Texas Health Science Center Houston, Houston, Texas |
Board Certifications
2015 | American Board of Radiology |
Experience & Service
Academic Appointments
Associate Professor, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2019 - 2024
Assistant Member, Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX, 2016 - 2021
Assistant Professor, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2014 - 2019
Institutional Committee Activities
Faculty Advisor, Advisory Council for Clinical Research Leaders, 2025 - Present
Faculty Lead, GI Radiation Oncology Clinical Research, 2023 - Present
Director, ACRC Program, 2020 - Present
Director, Assistant Research Coordinator Program, 2020 - 2023
Member, Radiation Oncology Technology Workstream Committee, 2020 - Present
GI Radiation Oncology Representative, Hepatocellular Carcinoma Algorithm Committee, 2020 - 2023
GI Radiation Oncology Representative, Pancreatic Adenocarcinoma Algorithm Committee, 2019 - 2023
Member, Cardiology Chair Search Committee, 2018
Co-Chair, New Technology Committee, GI Radiation Oncology, 2018 - Present
Member, Clinical Research Committee #3, 2017 - Present
GI Section Director, Cancer Network, UT MD Anderson Cancer Center, 2016 - 2018
Representative, SBRT QA Task Force, GI Radiation Oncology, 2015 - 2016
Liaison, GI Radiation Oncology partnership with Baptist Health, Jacksonville FL, 2015 - 2018
Liaison, UT MD Anderson Cancer Center Physicians Network, GI Radiation Oncology, 2015 - 2018
Primary Team Representative, Backfill Committee, GI Radiation Oncology, 2014 - 2015
Member, Residency Interview Committee, Department of Radiation Oncology, 2014
Member, Representative for MRI Linac Consortium with Elekta, GI Radiation Oncology, 2014 - Present
Member, EPIC Team Integration of Brocade System, GI Radiation Oncology, 2014 - Present
Honors & Awards
2020 - 2022 | NCTN Observer for Pancreas Task Force, NCI |
2019 | Therapeutic Advisory Group, Lustgarten Foundation |
2018 | NCI New Onset Diabetes (NOD) Cohort Committee Member for Imaging Working Group |
2018 | Radiation Oncology Working Group Co-Chair for International Cholangiocarcinoma Research Network |
2017 | Member of NCI Hepatobiliary Task Force |
2017 - 2019 | Andrew Sabin Family Fellows Award, Andrew Sabin Family Fellows Program |
2017 | NRG Junior Investigator representative for NCI Hepatobiliary Task Force |
2016 | Shirly Stein Scientific Endowed Research Award |
2016 | Co-mentor of Chad Tang, ASCO Young Investigator Award |
2016 | Featured in Oncology magazine “Transport Oncophysics could guide Pancreatic Cancer Treatment” by Jill Delsigne-Russell |
2016 | Mentor of Ahmed Elamir, KASO Grant Recipient |
2016 | Mentor of Alex Hanania, ARS Travel Award |
2016 | Mentor of Chad Tang, RSNA Resident Research Award |
2016 | Project Purple Grant for Early Detection of Pancreatic Cancer |
2015 | Faculty of 1000 Member |
2014 | Research Highlight in Cancer Discovery |
2014 | Gilbert H. Fletcher Resident Research Award |
2014 | PANCAN-AACR Career Development Award |
2014 | RSNA Seed Grant |
2012 - 2013 | Anne Eastland Spears Fellowship for GI Cancer Research |
2010 | Gold Foundation Humanism and Excellence in Teaching Award |
2009 | Research Highlight in Nature Clinical Practice: Rheumatology |
2008 | Honorable Mention, Sigma Xi Annual Thesis Award |
2007 | Mentor of Mukil Natarajan, Undergraduate Research Award |
2006 | Mentor of Zaven Sargsyan, NSF IGERT 1st place poster prize |
2006 | 2nd Place Poster at NSF IGERT Annual Retreat |
2006 | 3rd Place Poster at Rice BIOE Recruiting Weekend Poster Competition |
2006 | Mentor of Theodore John, Dean’s research scholar |
2004 | NSF IGERT Fellowship |
2001 | William W Akers Senior Process Design Award in Chemical Engineering |
2001 | BCM Medical Scientist Training Program (MSTP) Scholarship |
2001 | BMES Outstanding Undergraduate Research Design Award |
1998 - 1999 | W L Moody Scholarship |
1997 - 2001 | President’s Honor Roll |
1997 - 2001 | Robert C Byrd Scholarship |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Taylor, PA, Mirandola, A, Ciocca, M, Hartzell, S, Magro, G, Alvarez, PE, Peterson, CB, Peeler, CR, Koay, EJ, Howell, RM, Kry, SF. Characterization of LiF TLD-100 in carbon ion beams for remote audits. Medical physics 52(3):1858-1866, 2025. e-Pub 2025. PMID: 39718203.
- Ahmed, J, Knisely, A, Torrado, C, Stephen, B, Yang, Y, Song, J, Alshawa, A, Zarifa, A, Jhingran, A, Koay, EJ, Morris, VK, Javle, M, Wolff, RA, Meric-Bernstam, F, Pant, S, Rodon Ahnert, J, Naing, A. A phase I/II trial of avelumab combinations with ivuxolimab, utomilumab, and radiation therapy in patients with advanced gastrointestinal malignancies. Oncologist 30(3), 2025. e-Pub 2025. PMID: 40139261.
- Dawson LA, Winter KA, Knox JJ, Zhu AX, Krishnan S, Guha C, Kachnic LA, Gillin MT, Hong TS, Craig TD, Williams TM, Hosni A, Chen E, Noonan AM, Koay EJ, Sinha R, Lock MI, Ohri N, Dorth JA, Delouya G, Swaminath A, Moughan J, Crane CH. Stereotactic Body Radiotherapy vs Sorafenib Alone in Hepatocellular Carcinoma: The NRG Oncology/RTOG 1112 Phase 3 Randomized Clinical Trial. JAMA Oncol 11(2):136-144, 2025. e-Pub 2025. PMID: 39699905.
- Seo, YD, Acidi, B, Newton, A, Haddad, A, Chiang, YJ, Coelho, R, Newhook, TE, Tzeng, CD, Chun, YS, Ludmir, EB, Koay, EJ, Javle, M, Vauthey, JN, Tran Cao, HS. Defining the Role of Adjuvant Radiotherapy for Biliary Tract Cancers. Cancers 17(3), 2025. e-Pub 2025. PMID: 39941861.
- Yousef, M, Hurd, MW, Yousef, A, Ludmir, EB, Balachandran Pillai, A, Peterson, J, Koay, EJ, Albarouki, S, Tzeng, CW, Snyder, RA, Katz, MH, Wang, H, Overman, MJ, Maitra, A, Pant, S, Smaglo, BG, Wolff, RA, Yao, JC, Shen, JY, Zhao, D. Clinical and molecular characteristics of patients with brain metastasis secondary to pancreatic ductal adenocarcinoma. Oncologist 30(1), 2025. e-Pub 2025. PMID: 39014543.
- Butner, JD, Dogra, P, Chung, C, Koay, EJ, Welsh, J, Hong, DS, Cristini, V, Wang, Z. Hybridizing mechanistic modeling and deep learning for personalized survival prediction after immune checkpoint inhibitor immunotherapy. npj Systems Biology and Applications 10(1), 2024. e-Pub 2024. PMID: 39143136.
- Sherry, AD, Lin, TA, McCaw, ZR, Beck, EJ, Kouzy, R, Abi Jaoude, J, Passy, AH, Miller, AM, Kupferman, GS, Fuller, C, Thomas, CR, Koay, EJ, Tang, C, Msaouel, P, Ludmir, EB. Improving the clinical meaning of surrogate endpoints. International journal of cancer 155(11):1939-1943, 2024. e-Pub 2024. PMID: 39138841.
- Dogra, P, Shinglot, V, Ruiz Ramírez, J, Cave, J, Butner, JD, Schiavone, C, Duda, DG, Kaseb, A, Chung, C, Koay, EJ, Cristini, V, Ozpolat, B, Calin, GA, Wang, Z. Translational modeling-based evidence for enhanced efficacy of standard-of-care drugs in combination with anti-microRNA-155 in non-small-cell lung cancer. Molecular cancer 23(1), 2024. e-Pub 2024. PMID: 39095771.
- Patel, N, Celaya, A, Eltaher, M, Glenn, R, Savannah, KJ, Brock, K, Sanchez, JI, Calderone, T, Cleere, D, Elsaiey, A, Cagley, MC, Gupta, N, Victor, DW, Beretta, L, Koay, EJ, Netherton, T, Fuentes, DA. Training robust T1-weighted magnetic resonance imaging liver segmentation models using ensembles of datasets with different contrast protocols and liver disease etiologies. Scientific reports 14(1), 2024. e-Pub 2024. PMID: 39251664.
- Corrigan, KL, Andring, L, Das, P, Pfennig, C, Porter, KB, Ludmir, EB, Noticewala, SS, Minsky, B, Smith, GL, Koay, EJ, Koong, A, Arzola, A, Lee, SJ, Nelms, LS, Holliday, EB. Evaluating pre-consult patient education videos for patients with newly-diagnosed anal squamous cell carcinoma. Technical Innovations and Patient Support in Radiation Oncology 32, 2024. e-Pub 2024. PMID: 39403310.
- Sherry, AD, Lin, TA, McCaw, ZR, Beck, EJ, Kouzy, R, Abi Jaoude, J, Passy, AH, Miller, AM, Kupferman, GS, Fuller, C, Thomas, CR, Koay, EJ, Tang, C, Msaouel, P, Ludmir, EB. Off-Protocol Radiation Therapy in Phase 3 Metastatic Solid Tumor Trials. International Journal of Radiation Oncology Biology Physics 120(5):1239-1244, 2024. e-Pub 2024. PMID: 39352322.
- Ludmir, EB, Sherry, AD, Fellman, B, Liu, S, Bathala, TK, Haymaker, CL, Medina-Rosales, M, Reuben, A, Holliday, EB, Smith, GL, Noticewala, SS, Nicholas, S, Price, TR, Martin, RM, Perles, LA, Lee, SS, Lee, MS, Smaglo, BG, Huey, RW, Willis, JA, Zhao, D, Cohen, L, Taniguchi, C, Koay, EJ, Katz, MH, Wolff, RA, Das, P, Pant, S, Koong, A, Tang, C. Addition of Metastasis-Directed Therapy to Systemic Therapy for Oligometastatic Pancreatic Ductal Adenocarcinoma (EXTEND). Journal of Clinical Oncology 42(32):3795-3805, 2024. e-Pub 2024. PMID: 39102622.
- Martin, RM, Jensen, PJ, Perles, LA, Sawakuchi, GO, Das, P, Koay, EJ, Koong, A, Ludmir, EB, Niedzielski, JS, Beddar, S. Daily Diagnostic Quality Computed Tomography-on-Rails (CTOR) Image Guidance for Abdominal Stereotactic Body Radiation Therapy (SBRT). Cancers 16(22), 2024. e-Pub 2024. PMID: 39594725.
- Tino, R, Roach, MA, Fuentes, GD, Agrawal, A, Zaid, M, Cooper, DJ, Bajaj, N, Lin, R, Xiao, L, Mayo, LL, Wiederhold, LR, Shah, SJ, Tate, MK, Chronowski, G, Reddy, JP, Mezera, M, Mann, JM, Augspurger, ME, Otun, AO, Chambers, MS, Koay, EJ. Development and clinical implementation of a digital workflow utilizing 3D-printed oral stents for patients with head and neck cancer receiving radiotherapy. Oral Oncology 157, 2024. e-Pub 2024. PMID: 39024700.
- Taherian, M, Katz, MH, Prakash, L, Wei, D, Tong, YT, Lai, Z, Chatterjee, D, Wang, H, Kim, M, Tzeng, CD, Ikoma, N, Wolff, RA, Zhao, D, Koay, EJ, Maitra, A, Wang, H. The Association between Sampling and Survival in Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreaticoduodenectomy. Cancers 16(19), 2024. e-Pub 2024.
- Mohamed, YI, Lee, SS, Demir, T, Chamseddine, SM, Hu, ZI, Xiao, L, Elsayes, KM, Morris, JS, Wolff, RA, Hiatia, R, Qayyum, A, Rashid, A, Duda, DG, Yao, JC, Lapelusa, M, Koay, EJ, Mahvash, A, Al Azzam, A, Ileana Dumbrava, EE, Hassan, MM, Amin, HM, Kaseb, A. Circulating tumor DNA (ctDNA) as a biomarker of response to therapy in advanced Hepatocellular carcinoma treated with Nivolumab. Cancer Biomarkers 41(1):83-91, 2024. e-Pub 2024. PMID: 39269823.
- Tchelebi LT, Segovia D, Smith K, Shi Q, Fitzgerald TJ, Chuong MD, Zemla TJ, O'Reilly EM, Meyerhardt JA, Koay EJ, Lowenstein J, Shergill A, Katz MHG, Herman JM. Radiation Therapy Quality Assurance Analysis of Alliance A021501: Preoperative mFOLFIRINOX or mFOLFIRINOX plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the pancreas. Int J Radiat Oncol Biol Phys 120(1):111-119, 2024. e-Pub 2024. PMID: 38492812.
- Taylor PA, Mirandola A, Ciocca M, Hartzell S, Vai A, Alvarez P, Howell RM, Koay EJ, Peeler CR, Peterson CB, Kry SF. Technical note: Radiological clinical equivalence for phantom materials in carbon ion therapy. Med Phys 51(7):5154-5158, 2024. e-Pub 2024. PMID: 38598230.
- Li Q, Cristini V, Gupta A, Achour I, Barrett JC, Koay EJ. Clinical Validation of Mathematically Derived Early Tumor Dynamics for Solid Tumors in Response to Durvalumab. JCO Clin Cancer Inform 8:e2300254, 2024. e-Pub 2024. PMID: 38996196.
- Yu D, Kane MJ, Koay EJ, Wistuba II, Hobbs BP. Machine learning identifies prognostic subtypes of the tumor microenvironment of NSCLC. Sci Rep 14(1):15004, 2024. e-Pub 2024. PMID: 38951567.
- Bhutani MS, Narang AK, Ding K, Casey B, Krishnan K, Koay EJ, Hong TS, Herman JM, Griffin KH, Shin EJ. EUS-guided hydrogel injection to separate pancreatic head carcinoma from duodenum for enhanced radiotherapy: Multi-site feasibility study. Endosc Int Open 12(7):E861-E867, 2024. e-Pub 2024. PMID: 38989255.
- Shi C, De B, Tran Cao HS, Liu S, Florez MA, Kouzy R, Grippin AJ, Katz MHG, Tzeng CD, Ikoma N, Kim MP, Lee S, Willis J, Noticewala SS, Minsky BD, Smith GL, Holliday EB, Taniguchi CM, Koong AC, Das P, Ludmir EB, Koay EJ. Escalated-dose radiotherapy for unresected locally advanced pancreatic cancer: Patterns of care and survival in the United States. Cancer Med 13(12):e7434, 2024. e-Pub 2024. PMID: 38923407.
- Tran Cao HS, Witt RG, Elsayes KM, Baiomy AA, Xiao L, Palmquist S, Lee SS, Mohamed YI, Mahvash A, Tzeng CD, Chun YS, Koay EJ, Rashid A, Hassan MM, Yao JC, Vauthey JN, Kaseb AO. Development of a Novel Comprehensive Hepatocellular Carcinoma Outcome Prognostic Scoring System with Integration of Imaging Features. Oncologist 29(6):e803-e810, 2024. e-Pub 2024. PMID: 38159256.
- Taylor PA, Hartzell S, Mirandola A, Ciocca M, Magro G, Alvarez P, Peterson CB, Peeler CR, Koay EJ, Howell RM, Kry SF. OSLD nanoDot characterization for carbon radiotherapy dosimetry. Phys Med Biol 69(11), 2024. e-Pub 2024. PMID: 38663410.
- Rooney MK, Niedzielski JS, Salazar RM, Arzola A, Das P, Koay EJ, Koong A, Ludmir EB, Minsky BD, Noticewala S, Smith GL, Taniguchi C, Holliday EB. Long-Term Patient-Reported Dyspareunia After Definitive Chemoradiation for Anal Cancer: Using the Anterior Vaginal Wall as an Organ-at-Risk to Define an Actionable Dosimetric Goal. Adv Radiat Oncol 9(5):101449, 2024. e-Pub 2024. PMID: 38550361.
- Sherry, AD, Msaouel, P, Lin, TA, Abi Jaoude, J, Kouzy, R, Beck, EJ, Miller, AM, Passy, AH, Kupferman, GS, Koay, EJ, Fuller, C, Thomas, CR, McCaw, ZR, Ludmir, EB. Postprogression therapy and confounding for the estimated treatment effect on overall survival in phase III oncology trials. BMJ Oncology 3(1), 2024. e-Pub 2024. PMID: 39886131.
- Chang E, Wong FCL, Chasen BA, Erwin WD, Das P, Holliday EB, Koong AC, Ludmir EB, Minsky BD, Noticewala SS, Smith GL, Taniguchi CM, Rodriguez MJ, Beddar S, Martin-Paulpeter RM, Niedzielski JS, Sawakuchi GO, Schueler E, Perles LA, Xiao L, Szklaruk J, Park PC, Dasari AN, Kaseb AO, Kee BK, Lee SS, Overman MJ, Willis JA, Wolff RA, Tzeng CD, Vauthey JN, Koay EJ. Phase I Trial of SPECT-Guided Liver-Directed Radiotherapy for Patients with Low Functional Liver Volume. JNCI Cancer Spectr 8(3), 2024. e-Pub 2024. PMID: 38730548.
- Patel N, Eltaher M, Glenn R, Savannah KB, Brock K, Sanchez J, Calderone T, Cleere D, Elsaiey A, Cagley M, Gupta N, Victor D, Beretta L, Celaya A, Koay E, Netherton T, Fuentes D. Training Robust T1-Weighted Magnetic Resonance Imaging Liver Segmentation Models Using Ensembles of Datasets with Different Contrast Protocols and Liver Disease Etiologies. Res Sq, 2024. e-Pub 2024. PMID: 38746406.
- Dogra P, Shinglot V, Ruiz-Ramírez J, Cave J, Butner JD, Schiavone C, Duda DG, Kaseb AO, Chung C, Koay EJ, Cristini V, Ozpolat B, Calin GA, Wang Z. Translational modeling-based evidence for enhanced efficacy of standard-of-care drugs in combination with anti-microRNA-155 in non-small-cell lung cancer. medRxiv, 2024. e-Pub 2024. PMID: 38559070.
- Butner JD, Dogra P, Chung C, Koay EJ, Welsh JW, Hong DS, Cristini V, Wang Z. Hybridizing mechanistic mathematical modeling with deep learning methods to predict individual cancer patient survival after immune checkpoint inhibitor therapy. Res Sq, 2024. e-Pub 2024. PMID: 38586046.
- Cass SH, Tzeng CD, Prakash LR, Maxwell J, Snyder RA, Kim MP, Huey RW, Smaglo BG, Pant S, Koay EJ, Wolff RA, Lee JE, Katz MHG, Ikoma N. Trends Over Time in Recurrence Patterns and Survival Outcomes after Neoadjuvant Therapy and Surgery for Pancreatic Cancer. Ann Surg. e-Pub 2024. PMID: 38506042.
- Jain A, Gormly KL, Glyn T, Sammour T, Koay EJ, Oar A, Jameson MB, Smyth EC, Vatandoust S. Management of rectal cancer in the era of total neoadjuvant therapy and watch and wait: A multidisciplinary team discussion at the Australasian Gastro-Intestinal Trials Group (AGITG) Annual Scientific Meeting 2022. Asia Pac J Clin Oncol 20(1):71-80, 2024. e-Pub 2023. PMID: 37340953.
- Gupta AC, Cazoulat G, Al Taie M, Yedururi S, Rigaud B, Castelo A, Wood J, Yu C, O'Connor C, Salem U, Silva JAM, Jones AK, McCulloch M, Odisio BC, Koay EJ, Brock KK. Fully automated deep learning based auto-contouring of liver segments and spleen on contrast-enhanced CT images. Sci Rep 14(1):4678, 2024. e-Pub 2024. PMID: 38409252.
- Rooney, MK, Pasli, M, Chang, GJ, Das, P, Koay, EJ, Koong, A, Ludmir, EB, Minsky, B, Noticewala, SS, Peacock, O, Smith, GL, Holliday, EB. Patient-Reported Sexual Function, Bladder Function and Quality of Life for Patients with Low Rectal Cancers with or without a Permanent Ostomy. Cancers 16(1), 2024. e-Pub 2024. PMID: 38201580.
- Treekitkarnmongkol, W, Dai, J, Liu, S, Sankaran, D, Nguyen, T, Balasenthil, S, Hurd, MW, Chen, M, Katayama, H, Roy-Chowdhuri, S, Calin, GA, Brand, RE, Lampe, PD, Hu, T, Maitra, A, Koay, EJ, Killary, AM, Sen, S. Blood-Based microRNA Biomarker Signature of Early-Stage Pancreatic Ductal Adenocarcinoma With Lead-Time Trajectory in Prediagnostic Samples. Gastro Hep Advances 3(8):1098-1115, 2024. e-Pub 2024. PMID: 39529638.
- Yanagihara TK, Tepper JE, Moon AM, Barry A, Molla M, Seong J, Torres F, Apisarnthanarax S, Buckstein M, Cardenes H, Chang DT, Feng M, Guha C, Hallemeier CL, Hawkins MA, Hoyer M, Iwata H, Jabbour SK, Kachnic L, Kharofa J, Kim TH, Kirichenko A, Koay EJ, Makishima H, Mases J, Meyer JJ, Munoz-Schuffenegger P, Owen D, Park HC, Saez J, Sanford NN, Scorsetti M, Smith GL, Wo JY, Yoon SM, Lawrence TS, Reig M, Dawson LA. Defining Minimum Treatment Parameters of Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma: An Expert Consensus. Pract Radiat Oncol 14(2):134-145, 2024. e-Pub 2024. PMID: 38244026.
- Nikzad N, Fuentes DT, Roach M, Chowdhury T, Cagley M, Badawy M, Elkhesen A, Hassan M, Elsayes KM, Beretta L, Koay EJ, Jalal PK. Enhancement Pattern Mapping for Early Detection of Hepatocellular Carcinoma in Patients with Cirrhosis. J Hepatocell Carcinoma 11:595-606, 2024. e-Pub 2024. PMID: 38525156.
- Arzola A, Chang E, Rooney MK, Corrigan K, Das P, Ludmir EB, Koay EJ, Minsky BD, Smith GL, Messick C, Morris VK, Nebgen D, Crane CH, Holliday EB. Daily Vaginal Dilator Use During Radiation for Women with Squamous Cell Carcinoma of the Anus: Vaginal Wall Dosimetry and Patient-Reported Sexual Function. Pract Radiat Oncol 14(2):e105-e116, 2024. e-Pub 2024. PMID: 37898354.
- Narang AK, Hong TS, Ding K, Herman J, Meyer J, Thompson E, Bhutani MS, Krishnan K, Casey B, Shin EJ, Koay EJ. A Multi-Institutional Safety and Feasibility Study Exploring the Use of Hydrogel to Create Spatial Separation between the Pancreas and Duodenum in Patients with Pancreatic Cancer. Pract Radiat Oncol 14(4):e276-e282, 2024. e-Pub 2024. PMID: 38043645.
- Taniguchi CM, Frakes JM, Aguilera TA, Palta M, Czito B, Bhutani MS, Colbert LE, Abi Jaoude J, Bernard V, Pant S, Tzeng CD, Kim DW, Malafa M, Costello J, Mathew G, Rebueno N, Koay EJ, Das P, Ludmir EB, Katz MHG, Wolff RA, Beddar S, Sawakuchi GO, Moningi S, Slack Tidwell RS, Yuan Y, Thall PF, Beardsley RA, Holmlund J, Herman JM, Hoffe SE. Stereotactic body radiotherapy with or without selective dismutase mimetic in pancreatic adenocarcinoma: an adaptive, randomised, double-blind, placebo-controlled, phase 1b/2 trial. Lancet Oncol 24(12):1387-1398, 2023. e-Pub 2023. PMID: 38039992.
- Cazacu IM, Singh BS, Martin-Paulpeter RM, Beddar S, Chun S, Holliday EB, Koong AC, Das P, Koay EJ, Taniguchi C, Herman JM, Bhutani MS. Endoscopic Ultrasound-Guided Fiducial Placement for Stereotactic Body Radiation Therapy in Patients with Pancreatic Cancer. Cancers (Basel) 15(22), 2023. e-Pub 2023. PMID: 38001615.
- Cazoulat G, Gupta AC, Al Taie MM, Koay EJ, Brock KK. Analysis and prediction of liver volume change maps derived from computational tomography scans acquired pre- and post-radiation therapy. Phys Med Biol 68(20), 2023. e-Pub 2023. PMID: 37714187.
- Lin YM, Fellman BM, Taiji R, Paolucci I, Silva JAM, Koay EJ, Avritscher R, Mahvash A, Holliday EB, Lee SS, Kaseb AO, Das P, Vauthey JN, Odisio BC. Salvage Locoregional Therapy Following Progression After Radiotherapy for Hepatocellular Carcinoma Is Associated with Improved Outcomes. J Gastrointest Surg 27(9):1867-1875, 2023. e-Pub 2023. PMID: 37268830.
- De B, Upadhyay R, Liao K, Kumala T, Shi C, Dodoo G, Abi Jaoude J, Corrigan KL, Manzar GS, Marqueen KE, Bernard V, Lee SS, Raghav KPS, Vauthey JN, Tzeng CD, Tran Cao HS, Lee G, Wo JY, Hong TS, Crane CH, Minsky BD, Smith GL, Holliday EB, Taniguchi CM, Koong AC, Das P, Javle M, Ludmir EB, Koay EJ. Definitive Liver Radiotherapy for Intrahepatic Cholangiocarcinoma with Extrahepatic Metastases. Liver Cancer 12(3):198-208, 2023. e-Pub 2023. PMID: 37593365.
- Chamseddine I, Kim Y, De B, Naqa IE, Duda DG, Wolfgang JA, Pursley J, Wo JY, Hong TS, Paganetti H, Koay EJ, Grassberger C. Predictive Model of Liver Toxicity to Aid the Personalized Selection of Proton Versus Photon Therapy in Hepatocellular Carcinoma. Int J Radiat Oncol Biol Phys 116(5):1234-1243, 2023. e-Pub 2023. PMID: 36739920.
- Ngo-Huang AT, Parker NH, Xiao L, Schadler KL, Petzel MQB, Prakash LR, Kim MP, Tzeng CD, Lee JE, Ikoma N, Wolff RA, Javle MM, Koay EJ, Pant SD, Folloder JP, Wang X, Cotto AM, Ju YR, Garg N, Wang H, Bruera ED, Basen-Engquist KM, Katz MHG. Effects of a Pragmatic Home-based Exercise Program Concurrent with Neoadjuvant Therapy on Physical Function of Patients with Pancreatic Cancer: The Pancfit Randomized Clinical Trial. Ann Surg 278(1):22-30, 2023. e-Pub 2023. PMID: 37026453.
- Liang TZ, Katz MHG, Prakash LR, Chatterjee D, Wang H, Kim M, Tzeng CD, Ikoma N, Wolff RA, Zhao D, Koay EJ, Maitra A, Kundu S, Wang H. Comparative Analyses of the Clinicopathologic Features of Short-Term and Long-Term Survivors of Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreatoduodenectomy. Cancers (Basel) 15(12), 2023. e-Pub 2023. PMID: 37370842.
- Rooney MK, De B, Corrigan K, Smith GL, Taniguchi C, Minsky BD, Ludmir EB, Koay EJ, Das P, Koong AC, Peacock O, Chang G, You YN, Morris VK, Nogueras-González G, Holliday EB. Patient-reported Bowel Function and Bowel-related Quality of Life After Pelvic Radiation for Rectal Adenocarcinoma: The Impact of Radiation Fractionation and Surgical Resection. Clin Colorectal Cancer 22(2):211-221, 2023. e-Pub 2023. PMID: 36878805.
- Tong YT, Lai Z, Katz MHG, Prakash LR, Wang H, Chatterjee D, Kim M, Tzeng CD, Lee JE, Ikoma N, Rashid A, Wolff RA, Zhao D, Koay EJ, Maitra A, Wang H. Prognosticators for Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Therapy and Pancreatectomy. Cancers (Basel) 15(9), 2023. e-Pub 2023. PMID: 37174073.
- Sohn AJ, Taherian M, Katz MHG, Prakash LR, Chatterjee D, Wang H, Kim M, Tzeng CD, Lee JE, Ikoma N, Rashid A, Wolff RA, Zhao D, Koay EJ, Sun R, Maitra A, Wang H. Integrated Pathologic Score Effectively Stratifies Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreaticoduodenectomy. Am J Surg Pathol 47(4):421-430, 2023. e-Pub 2023. PMID: 36746143.
- Dodoo GN, De B, Lee SS, Abi Jaoude J, Vauthey JN, Tzeng CD, Tran Cao HS, Katlowitz KA, Mandel JJ, Beckham TH, Minsky BD, Smith GL, Holliday EB, Koong AC, Das P, Taniguchi CM, Javle M, Koay EJ, Ludmir EB. Brain Metastases from Biliary Tract Cancer: Case Series and Clinicogenomic Analysis. Oncologist 28(4):327-332, 2023. e-Pub 2023. PMID: 36715178.
- Newhook TE, Vreeland TJ, Griffin JF, Tidwell RSS, Prakash LR, Koay EJ, Ludmir EB, Smaglo BG, Pant S, Overman M, Wolff RA, Ikoma N, Maxwell J, Kim MP, Lee JE, Katz MHG, Tzeng CD. Prognosis Associated with CA19-9 Response Dynamics and Normalization During Neoadjuvant Therapy in Resected Pancreatic Adenocarcinoma. Ann Surg 277(3):484-490, 2023. e-Pub 2023. PMID: 36649067.
- Hernandez S, Das P, Holliday EB, Shen L, Lu W, Johnson B, Messick CA, Taniguchi CM, Skibber J, Ludmir EB, You YN, Smith GL, Bednarski B, Kostousov L, Koay EJ, Minsky BD, Tillman M, Portier S, Eng C, Koong AC, Chang GJ, Foo WC, Wang J, Soto LS, Morris VK. Differential Spatial Gene and Protein Expression Associated with Recurrence Following Chemoradiation for Localized Anal Squamous Cell Cancer. Cancers (Basel) 15(6), 2023. e-Pub 2023. PMID: 36980587.
- Rhee DJ, Beddar S, Jaoude JA, Sawakuchi G, Martin R, Perles L, Yu C, He Y, Court LE, Ludmir EB, Koong AC, Das P, Koay EJ, Taniguichi C, Niedzielski JS. Dose Escalation for Pancreas SBRT: Potential and Limitations of using Daily Online Adaptive Radiation Therapy and an Iterative Isotoxicity Automated Planning Approach. Adv Radiat Oncol 8(4):101164, 2023. e-Pub 2023. PMID: 36798731.
- Patel M, Dayan I, Fishman EK, Flores M, Gilbert FJ, Guindy M, Koay EJ, Rosenthal M, Roth HR, Linguraru MG. Accelerating artificial intelligence: How federated learning can protect privacy, facilitate collaboration, and improve outcomes. Health Informatics J 29(4):14604582231207744, 2023. e-Pub 2023. PMID: 37864543.
- Kang Y, Deng J, Ling J, Li X, Chiang YJ, Koay EJ, Wang H, Burks JK, Chiao PJ, Hurd MW, Bhutani MS, Lee JH, Weston BR, Maitra A, Ikoma N, Tzeng CD, Lee JE, DePinho RA, Wolff RA, Pant S, McAllister F, Katz MH, Fleming JB, Kim MP. 3D imaging analysis on an organoid-based platform guides personalized treatment in pancreatic ductal adenocarcinoma. J Clin Invest 132(24), 2022. e-Pub 2022. PMID: 36282600.
- Koay EJ, Zaid M, Aliru M, Bagereka P, Van Wieren A, Rodriguez MJ, Jacobson G, Wolff RA, Overman M, Varadhachary G, Pant S, Wang H, Tzeng CW, Ikoma N, Kim M, Lee JE, Katz MH, Tamm E, Bhosale P, Taniguchi CM, Holliday EB, Smith GL, Ludmir EB, Minsky BD, Crane CH, Koong AC, Das P, Wang X, Javle M, Krishnan S. Nab-Paclitaxel, Capecitabine, and Radiation Therapy Following Induction Chemotherapy in Treating Patients with Locally Advanced and Borderline Resectable Pancreatic Cancer: Phase I Trial and Imaging-based Biomarker Validation. Int J Radiat Oncol Biol Phys 114(3):444-453, 2022. e-Pub 2022. PMID: 35863672.
- Scherer, JA, Gebhard, R, Firkins, SA, Shah, ZK, Urbina Andersson, IK, Barker, SJ, Fiorillo, LE, Hollander, E, Shaheen, N, Koay, EJ, Conwell, DL, Krishna, SG. Lower Interobserver Reliability for Nondimensional Intracystic Features Among Abdominal Radiologists for Characterizing Intraductal Papillary Mucinous Neoplasms Using Magnetic Resonance Imaging. Pancreas 51(9):1225-1230, 2022. e-Pub 2022. PMID: 37078949.
- Khan Z, Rooney MK, Das P, Ludmir EB, Koay EJ, Smith GL, Taniguchi C, Minsky BD, Koong AC, Sawakuchi G, Beddar S, Martin RM, Rodriguez-Bigas M, Peacock O, Chang G, Holliday EB. Intraoperative Radiation After Pelvic Short Course Radiation-Based Total Neoadjuvant Therapy for Patients with Rectal Adenocarcinoma at High Risk for Local Recurrence. Clin Colorectal Cancer 21(3):204-211, 2022. e-Pub 2022. PMID: 35125321.
- Corrigan KL, Rooney MK, De B, Ludmir ED, Das P, Smith GL, Taniguchi C, Minsky BD, Koay EJ, Koong A, Morris VK, Messick CA, Nogueras-Gonzalez G, Holliday EB. Patient-reported sexual function in long-term survivors of anal cancer treated with definitive intensity-modulated radiotherapy and concurrent chemotherapy. Pract Radiat Oncol 12(5):e397-e405, 2022. e-Pub 2022. PMID: 35643295.
- De B, Corrigan KL, Rooney MK, Ludmir EB, Das P, Smith GL, Taniguchi CM, Minsky BD, Koay EJ, Koong A, Morris VK, Messick CA, You YN, Chang GJ, Westney OL, Nogueras Gonzalez GM, Holliday EB. Patient-reported bowel and urinary function in long-term survivors of squamous cell carcinoma of the anus treated with definitive intensity-modulated radiotherapy and concurrent chemotherapy. Int J Radiat Oncol Biol Phys 114(1):78-88, 2022. e-Pub 2022. PMID: 35589011.
- Wang CX, Elganainy D, Zaid MM, Butner JD, Agrawal A, Nizzero S, Minsky BD, Holliday EB, Taniguchi CM, Smith GL, Koong AC, Herman JM, Das P, Maitra A, Wang H, Wolff RA, Katz MHG, Crane CH, Cristini V, Koay EJ. Mass transport model of radiation response: calibration and application to chemoradiation for pancreatic cancer. Int J Radiat Oncol Biol Phys 114(1):163-172, 2022. e-Pub 2022. PMID: 35643254.
- Moningi S, Lei X, Fang P, Taniguchi CM, Holliday EB, Koay EJ, Koong AC, Ludmir EB, Minsky BD, Das P, Giordano SH, Smith GL. Contemporary use and outcomes of radiation and chemotherapy for unresectable pancreatic cancer. Clin Transl Radiat Oncol 35:9-16, 2022. e-Pub 2022. PMID: 35510142.
- De B, Tran Cao HS, Vauthey JN, Manzar GS, Corrigan KL, Raghav KPS, Lee SS, Tzeng CD, Minsky BD, Smith GL, Holliday EB, Taniguchi CM, Koong AC, Das P, Javle M, Ludmir EB, Koay EJ. Ablative liver radiotherapy for unresected intrahepatic cholangiocarcinoma: Patterns of care and survival in the United States. Cancer 128(13):2529-2539, 2022. e-Pub 2022. PMID: 35417569.
- Corrigan KL, De B, Rooney MK, Ludmir EB, Das P, Smith GL, Taniguchi CM, Minsky BD, Koay EJ, Koong AC, Holliday EB. Patient-Reported Outcomes After Chemoradiation in Patients with Anal Cancer: A Qualitative Analysis. Adv Radiat Oncol 7(4):100986, 2022. e-Pub 2022. PMID: 35662810.
- Hernandez S, Parra ER, Uraoka N, Tang X, Shen Y, Qiao W, Jiang M, Zhang S, Mino B, Lu W, Pandurengan R, Haymaker C, Affolter K, Scaife CL, Yip-Schneider M, Schmidt CM, Firpo MA, Mulvihill SJ, Koay EJ, Wang H, Wistuba II, Maitra A, Solis LM, Sen S. Diminished Immune Surveillance during Histologic Progression of Intraductal Papillary Mucinous Neoplasms Offers a Therapeutic Opportunity for Cancer Interception. Clin Cancer Res 28(9):1938-1947, 2022. e-Pub 2022. PMID: 35491652.
- Manzar GS, De BS, Abana CO, Lee SS, Javle M, Kaseb AO, Vauthey JN, Tran Cao HS, Koong AC, Smith GL, Taniguchi CM, Holliday EB, Das P, Koay EJ, Ludmir EB. Outcomes and Toxicities of Modern Combined Modality Therapy with Atezolizumab Plus Bevacizumab and Radiation Therapy for Hepatocellular Carcinoma. Cancers (Basel) 14(8), 2022. e-Pub 2022. PMID: 35454808.
- Taku N, Yi-Qian YN, Chang GJ, Ludmir EB, Raghav KPS, Rodriguez-Bigas MA, Holliday EB, Smith GL, Minsky BD, Overman MJ, Messick C, Boyce-Fappiano D, Koong AC, Skibber JM, Koay EJ, Dasari A, Taniguchi CM, Bednarski BK, Morris VK, Kopetz S, Das P. Benchmarking Outcomes for Definitive Treatment of Young-Onset, Locally Advanced Rectal Cancer. Clin Colorectal Cancer 21(1):e28-e37, 2022. e-Pub 2022. PMID: 34794903.
- Colbert LE, El MB, Lynn EJ, Bronk J, Karpinets TV, Wu X, Chapman BV, Sims TT, Lin D, Kouzy R, Sammouri J, Biegert G, Delgado Medrano AY, Olvera A, Sastry KJ, Eifel PJ, Jhingran A, Lin L, Ramondetta LM, Futreal AP, Jazaeri AA, Schmeler KM, Yue J, Mitra A, Yoshida-Court K, Wargo JA, Solley TN, Hegde V, Nookala SS, Yanamandra AV, Dorta-Estremera S, Mathew G, Kavukuntla R, Papso C, Ahmed-Kaddar M, Kim M, Zhang J, Reuben A, Holliday EB, Minsky BD, Koong AC, Koay EJ, Das P, Taniguchi CM, Klopp A. Expansion of Candidate HPV-Specific T Cells in the Tumor Microenvironment during Chemoradiotherapy Is Prognostic in HPV16+ Cancers. Cancer Immunol Res 10(2):259-271, 2022. e-Pub 2022. PMID: 35045973.
- Chamseddine I, Kim Y, De B, El Naqa I, Duda DG, Wolfgang J, Pursley J, Paganetti H, Wo J, Hong T, Koay EJ, Grassberger C. Predictive Modeling of Survival and Toxicity in Patients with Hepatocellular Carcinoma After Radiotherapy. JCO Clin Cancer Inform 6(6):e2100169, 2022. e-Pub 2022. PMID: 35192402.
- Holliday, EB, Morris, VK, Johnson, B, Eng, C, Ludmir, EB, Das, P, Minsky, B, Taniguchi, C, Smith, GL, Koay, EJ, Koong, A, Delclos, ME, Skibber, JM, Rodriguez-Bigas, MA, You, YN, Bednarski, BK, Tillman, MM, Chang, GJ, Jennings, K, Messick, C. Definitive Intensity-Modulated Chemoradiation for Anal Squamous Cell Carcinoma. Oncologist 27(1):40-47, 2022. e-Pub 2022. PMID: 35305097.
- Apisarnthanarax, S, Barry, A, Cao, M, Czito, BG, Dematteo, RP, Drinane, M, Hallemeier, C, Koay, EJ, Lasley, F, Meyer, JJ, Owen, D, Pursley, J, Schaub, SK, Smith, GL, Venepalli, N, Zibari, G, Cardenes, HR. External Beam Radiation Therapy for Primary Liver Cancers. Practical radiation oncology 12(1):28-51, 2022. e-Pub 2022. PMID: 34688956.
- Chamseddine I, Kim Y, De B, El Naqa I, Duda DG, Wolfgang J, Pursley J, Paganetti H, Wo J, Hong T, Koay EJ, Grassberger C. Predictive Modeling of Survival and Toxicity in Hepatocellular Carcinoma Patients After Radiotherapy. JCO Clinical Cancer Informatics, 2022. e-Pub 2022.
- Douglas JE, Liu S, Ma J, Wolff RA, Pant S, Maitra A, Tamm EP, Bhosale P, Katz MHG, Varadhachary GR, Koay EJ. PIONEER-Panc: a platform trial for phase II randomized investigations of new and emerging therapies for localized pancreatic cancer. BMC Cancer 22(1):14, 2022. e-Pub 2022. PMID: 34980020.
- McCulloch MM, Cazoulat G, Svensson S, Gryshkevych S, Rigaud B, Anderson BM, Kirimli E, De B, Mathew RT, Zaid M, Elganainy D, Peterson CB, Balter P, Koay EJ, Brock KK. Leveraging deep learning-based segmentation and contours-driven deformable registration for dose accumulation in abdominal structures. Front Oncol 12:1015608, 2022. e-Pub 2022. PMID: 36408172.
- Niedzielski JS, Liu Y, Ng SSW, Martin RM, Perles LA, Beddar S, Rebueno N, Koay EJ, Taniguchi C, Holliday EB, Das P, Smith GL, Minsky BD, Ludmir EB, Herman JM, Koong A, Sawakuchi GO. Dosimetric uncertainties resulting from interfractional anatomic variations for patients receiving pancreas stereotactic body radiation therapy and cone-beam CT image guidance. Int J Radiat Oncol Biol Phys 111(5):1298-1309, 2021. e-Pub 2021. PMID: 34400267.
- De B, Abu-Gheida I, Patel A, Ng SSW, Zaid M, Thunshelle CP, Elganainy D, Corrigan KL, Rooney MK, Javle M, Raghav K, Lee SS, Vauthey JN, Tzeng CD, Tran Cao HS, Ludmir EB, Minsky BD, Smith GL, Holliday EB, Taniguchi CM, Koong AC, Das P, Koay EJ. Benchmarking Outcomes after Ablative Radiotherapy for Molecularly Characterized Intrahepatic Cholangiocarcinoma. J Pers Med 11(12), 2021. e-Pub 2021. PMID: 34945742.
- Abi Jaoude, J, Thunshelle, CP, Kouzy, R, Nguyen, ND, Lin, D, Prakash, L, Bumanlag, IM, Noticewala, SS, Niedzielski, JS, Beddar, S, Ludmir, EB, Holliday, EB, Das, P, Minsky, B, Herman, JM, Katz, MH, Koong, A, Koay, EJ, Taniguchi, C. Stereotactic Versus Conventional Radiation Therapy for Patients With Pancreatic Cancer in the Modern Era. Advances in Radiation Oncology 6(6), 2021. e-Pub 2021. PMID: 34934858.
- Butner JD, Martin GV, Wang Z, Corradetti B, Ferrari M, Esnaola N, Chung C, Hong DS, Welsh JW, Hasegawa N, Mittendorf EA, Curley SA, Chen SH, Pan PY, Libutti SK, Ganesan S, Sidman RL, Pasqualini R, Arap W, Koay EJ, Cristini V. Early prediction of clinical response to checkpoint inhibitor therapy in human solid tumors through mathematical modeling. Elife 10, 2021. e-Pub 2021. PMID: 34749885.
- De, BS, Ludmir, EB, Messick, C, Cagley, MC, Morris, VK, Das, P, Minsky, B, Taniguchi, C, Smith, GL, Koay, EJ, Koong, A, Mohan, R, Holliday, EB. Prognostic impact of lymphopenia and neutrophil-lymphocyte ratio for patients with anal squamous cell carcinoma. Journal of Gastrointestinal Oncology 12(5):2412-2422, 2021. e-Pub 2021. PMID: 34790402.
- Sebastian NT, Webb A, Merrell KW, Koay EJ, Wolfe AR, Zhang L, Wilhite TJ, Elganainy D, Robb R, Chen W, Cloyd J, Dillhoff M, Tsung A, Abushahin L, Noonan A, Williams TM. Development of a MicroRNA Signature Predictive of Recurrence and Survival in Pancreatic Ductal Adenocarcinoma. Cancers (Basel) 13(20), 2021. e-Pub 2021. PMID: 34680317.
- Cazoulat G, Anderson BM, McCulloch MM, Rigaud B, Koay EJ, Brock KK. Detection of vessel bifurcations in CT scans for automatic objective assessment of deformable image registration accuracy. Med Phys, 2021. e-Pub 2021. PMID: 34390007.
- Tong YT, Wang H, Wei D, Prakash LR, Kim M, Tzeng CD, Lee JE, Rashid A, Koay EJ, Wolff RA, Maitra A, Katz MH, Wang H. GRP78 expression and prognostic significance in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant therapy versus surgery first. Pancreatology 21(7):1378-1385, 2021. e-Pub 2021. PMID: 34429247.
- Christopherson KM, Das P, Berlind C, Lindsay WD, Ahern C, Smith BD, Subbiah IM, Koay EJ, Koong AC, Holliday EB, Ludmir EB, Minsky BD, Taniguchi CM, Smith GL. A Machine Learning Model Approach to Risk-Stratify Gastrointestinal (GI) Cancer Patients for Hospitalization and Mortality Outcomes. Int J Radiat Oncol Biol Phys 111(1):135-142, 2021. e-Pub 2021. PMID: 33933480.
- Palasi S, Zhang N, Bankston M, Godby J, Burrows H, Lagunas J, Perkison W, Gunn B, Chambers MS, Rosenthal DI, Morrison W, Garden A, Fuller CD, Giordano S, Koay EJ. Factors associated with complex oral treatment device usage in patients with head and neck cancer. Clin Transl Radiat Oncol 30:78-83, 2021. e-Pub 2021. PMID: 34430717.
- Deng J, Kang Y, Cheng CC, Li X, Dai B, Katz MH, Men T, Kim MP, Koay E, Huang H, Brekken RA, Fleming JB. Ddr1-induced neutrophil extracellular traps drive pancreatic cancer metastasis. JCI Insight 6(17), 2021. e-Pub 2021. PMID: 34237033.
- Kim MP, Li X, Deng J, Zhang Y, Dai B, Allton KL, Hughes TG, Siangco C, Augustine JJ, Kang Y, McDaniel JM, Xiong S, Koay EJ, McAllister F, Bristow CA, Heffernan TP, Maitra A, Liu B, Barton MC, Wasylishen AR, Fleming JB, Lozano G. Oncogenic KRAS recruits an expansive transcriptional network through mutant p53 to drive pancreatic cancer metastasis. Cancer Discov 11(8):2094-2111, 2021. e-Pub 2021. PMID: 33839689.
- Le O, Javadi S, Bhosale PR, Koay EJ, Katz MH, Sun J, Yang W, Tamm EP. CT features predictive of nodal positivity at surgery in pancreatic cancer patients following neoadjuvant therapy in the setting of dual energy CT. Abdom Radiol (NY) 46(6):2620-2627, 2021. e-Pub 2021. PMID: 33471129.
- Hester R, Advani S, Rashid A, Holliday E, Messick C, Das P, You YN, Taniguchi C, Koay EJ, Bednarski B, Rodriguez-Bigas M, Skibber J, Wolff R, Chang GJ, Minsky BD, Foo WC, Rothschild N, Morris VK, Eng C. CEA as a blood-based biomarker in anal cancer. Oncotarget 12(11):1037-1045, 2021. e-Pub 2021. PMID: 34084278.
- Dogra P, Koay EJ, Wang Z, Vahidy FS, Ferrari M, Pasqualini R, Arap W, Boom ML, Dirk Sostman H, Cristini V. Is the worst of the COVID-19 global pandemic yet to come? Application of financial mathematics as candidate predictive tools. Transl Psychiatry 11(1):299, 2021. e-Pub 2021. PMID: 34016952.
- Perri G, Prakash L, Wang H, Bhosale P, Varadhachary GR, Wolff R, Fogelman D, Overman M, Pant S, Javle M, Koay E, Herman J, Kim M, Ikoma N, Tzeng CW, Lee JE, Katz MHG. Radiographic and Serologic Predictors of Pathologic Major Response to Preoperative Therapy for Pancreatic Cancer. Ann Surg 273(4):806-813, 2021. e-Pub 2021. PMID: 31274655.
- Butner JD, Wang Z, Elganainy D, Al Feghali KA, Plodinec M, Calin GA, Dogra P, Nizzero S, Ruiz-Ramírez J, Martin GV, Tawbi HA, Chung C, Koay EJ, Welsh JW, Hong DS, Cristini V. A mathematical model for the quantification of a patient's sensitivity to checkpoint inhibitors and long-term tumour burden. Nat Biomed Eng 5(4):297-308, 2021. e-Pub 2021. PMID: 33398132.
- Augustyn A, Reed VI, Ahmad N, Bhutani MS, Bloom ES, Bowers JR, Chronowski GM, Das P, Holliday EB, Delclos ME, Huey RW, Koay EJ, Lee SS, Nelson CL, Taniguchi CM, Koong AC, Chun SG. Implementation of a stereotactic body radiotherapy program for unresectable pancreatic cancer in an integrated community academic radiation oncology satellite network. Clin Transl Radiat Oncol 27:147-151, 2021. e-Pub 2021. PMID: 33665384.
- Moningi S, Abi Jaoude J, Kouzy R, Lin D, Nguyen ND, Garcia Garcia CJ, Phan JL, Avila S, Smani D, Cazacu IM, Singh BS, Smith GL, Holliday EB, Koay EJ, Das P, Bhutani MS, Herman JM, Minsky BD, Koong AC, Taniguchi CM. Impact of Fiducial Marker Placement Before Stereotactic Body Radiation Therapy on Clinical Outcomes in Patients With Pancreatic Cancer. Adv Radiat Oncol 6(2):100621, 2021. e-Pub 2021. PMID: 33912734.
- Xu, M, Tapia, C, Hajjar, J, Sabir, SH, Colen, R, Nagarajan, P, Aung, PP, Gong, J, Rodon Ahnert, J, Fu, S, Stephen, B, Roy Chowdhuri, S, Le, H, Yang, V, Zarifa, A, Abdelsalam, ME, Jhingran, A, Javle, M, Pant, S, Carter, B, Milton, D, Sun, R, Karp, DD, Koay, EJ, Yang, Y, Wistuba, II, Hwu, P, Meric-Bernstam, F, Naing, A. Implementation of a novel web-based lesion selection tool to improve acquisition of tumor biopsy specimens. Journal of Immunotherapy and Precision Oncology 4(2):45-52, 2021. e-Pub 2021. PMID: 35663531.
- Wei D, Zaid MM, Katz MH, Prakash LR, Kim M, Tzeng CD, Lee JE, Agrawal A, Rashid A, Wang H, Varadhachary G, Wolff RA, Tamm EP, Bhosale PR, Maitra A, Koay EJ, Wang H. Clinicopathological correlation of radiologic measurement of post-therapy tumor size and tumor volume for pancreatic ductal adenocarcinoma. Pancreatology 21(1):200-207, 2021. e-Pub 2021. PMID: 33221151.
- Dogra P, Koay EJ, Wang Z, Vahidy FS, Ferrari M, Pasqualini R, Arap W, Boom ML, Sostman HD, Cristini V. Do Pandemics Obey the Elliott Wave Principle of Financial Markets?. medRxiv, 2021. e-Pub 2021. PMID: 33501456.
- Anderson BM, Lin EY, Cardenas CE, Gress DA, Erwin WD, Odisio BC, Koay EJ, Brock KK. Automated Contouring of Contrast and Noncontrast Computed Tomography Liver Images with Fully Convolutional Networks. Adv Radiat Oncol 6(1):100464, 2021. e-Pub 2021. PMID: 33490720.
- Rahmanuddin S, Korn R, Cridebring D, Borazanci E, Brase J, Boswell W, Jamil A, Cai W, Sabir A, Motarjem P, Koay E, Mitra A, Goel A, Ho J, Chung V, Von Hoff DD. Role of 3D Volumetric and Perfusion Imaging for Detecting Early Changes in Pancreatic Adenocarcinoma. Front Oncol 11:678617, 2021. e-Pub 2021. PMID: 34568010.
- De B, Ng SP, Liu AY, Avila S, Tao R, Holliday EB, Brownlee Z, Kaseb A, Lee S, Raghav K, Vauthey JN, Minsky BD, Herman JM, Das P, Smith GL, Taniguchi CM, Krishnan S, Crane CH, Grassberger C, Hong TS, Lin SH, Koong AC, Mohan R, Koay EJ. Radiation-Associated Lymphopenia and Outcomes of Patients with Unresectable Hepatocellular Carcinoma Treated with Radiotherapy. J Hepatocell Carcinoma 8:57-69, 2021. e-Pub 2021. PMID: 33688489.
- Kouzy R, Abi Jaoude J, Lin D, El Alam MB, Minsky BD, Koay EJ, Das P, Holliday EB, Klopp AH, Colbert LE, Taniguchi CM. Patient-Reported GI Outcomes in Patients with Anal Cancer Receiving Modern Chemoradiation. JCO Oncol Pract 16(12):OP2000122, 2020. e-Pub 2020. PMID: 32609585.
- Zaid M, Widmann L, Dai A, Sun K, Zhang J, Zhao J, Hurd MW, Varadhachary GR, Wolff RA, Maitra A, Katz MHG, Herman JM, Wang H, Knopp MV, Williams TM, Bhosale P, Tamm EP, Koay EJ. Predictive Modeling for Voxel-Based Quantification of Imaging-Based Subtypes of Pancreatic Ductal Adenocarcinoma (PDAC): A Multi-Institutional Study. Cancers (Basel) 12(12), 2020. e-Pub 2020. PMID: 33291471.
- Slagowski JM, Colbert LE, Cazacu IM, Singh BS, Martin R, Koay EJ, Taniguchi CM, Koong AC, Bhutani MS, Herman JM, Beddar S. Evaluation of the Visibility and Artifacts of 11 Common Fiducial Markers for Image Guided Stereotactic Body Radiation Therapy in the Abdomen. Pract Radiat Oncol 10(6):434-442, 2020. e-Pub 2020. PMID: 31988039.
- Koay EJ, Hanania AN, Hall WA, Taniguchi CM, Rebueno N, Myrehaug S, Aitken KL, Dawson LA, Crane CH, Herman JM, Erickson B. Dose-Escalated Radiation Therapy for Pancreatic Cancer: A Simultaneous Integrated Boost Approach. Pract Radiat Oncol 10(6):e495-e507, 2020. e-Pub 2020. PMID: 32061993.
- Perri G, Prakash L, Malleo G, Caravati A, Varadhachary GR, Fogelman D, Pant S, Koay EJ, Herman J, Maggino L, Milella M, Kim M, Ikoma N, Tzeng CW, Salvia R, Lee JE, Bassi C, Katz MHG. The Sequential Radiographic Effects of Preoperative Chemotherapy and (Chemo)Radiation on Tumor Anatomy in Patients with Localized Pancreatic Cancer. Ann Surg Oncol 27(10):3939-3947, 2020. e-Pub 2020. PMID: 32266574.
- Sharib J, Esserman L, Koay EJ, Maitra A, Shen Y, Kirkwood KS, Ozanne EM. Cost-effectiveness of consensus guideline-based management of pancreatic cysts: The sensitivity and specificity required for guidelines to be cost-effective. Surgery 168(4):601-609, 2020. e-Pub 2020. PMID: 32739138.
- Stieb S, Perez-Martinez I, Mohamed ASR, Rock S, Bajaj N, Deshpande TS, Zaid M, Garden AS, Goepfert RP, Cardoso R, Ferrarotto R, Reddy JP, Phan J, Morrison WH, Rosenthal DI, Koay EJ, Frank SJ, Fuller CD, Gunn GB, Head MD, Working Group NCS. The impact of tongue-deviating and tongue-depressing oral stents on long-term radiation-associated symptoms in oropharyngeal cancer survivors. Clin Transl Radiat Oncol 24:71-78, 2020. e-Pub 2020. PMID: 32642562.
- Perri G, Prakash L, Qiao W, Varadhachary GR, Wolff R, Fogelman D, Overman M, Pant S, Javle M, Koay EJ, Herman J, Kim M, Ikoma N, Tzeng CW, Lee JE, Katz MHG. Response and Survival Associated with First-line FOLFIRINOX vs Gemcitabine and nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma. JAMA Surg 155(9):832-839, 2020. e-Pub 2020. PMID: 32667641.
- Zaid M, Koay EJ, Bajaj N, Mathew R, Xiao L, Agrawal A, Fernandes P, Burrows H, Roach MA, Wilke CT, Chung C, Fuller CD, Phan J, Gunn GB, Morrison WH, Garden AS, Frank SJ, Rosenthal DI, Andersen M, Otun A, Chambers MS. A prospective parallel design study testing non-inferiority of customized oral stents made using 3D printing or manually fabricated methods. Oral Oncol 106:104665, 2020. e-Pub 2020. PMID: 32298994.
- Perri G, Prakash L, Qiao W, Varadhachary GR, Wolff R, Fogelman D, Overman M, Pant S, Javle M, Koay EJ, Herman J, Kim M, Ikoma N, Tzeng CW, Lee JE, Katz MHG. Postoperative Chemotherapy Benefits Patients Who Received Preoperative Therapy and Pancreatectomy for Pancreatic Adenocarcinoma. Ann Surg 271(6):996-1002, 2020. e-Pub 2020. PMID: 31895709.
- Avila S, Chang GJ, Dasari NA, Smani DA, Das P, Herman JM, Koay E, Koong A, Krishnan S, Minsky BD, Smith GL, Taniguchi C, Taggart MW, Kaur H, Holliday EB. Pathologic Response and Postoperative Complications After Short-course Radiation Therapy and Chemotherapy for Patients with Rectal Adenocarcinoma. Clin Colorectal Cancer 19(2):116-122, 2020. e-Pub 2020. PMID: 32173279.
- Hasan S, Abel S, Uemura T, Verma V, Koay EJ, Herman J, Thai N, Kirichenko A. Liver transplant mortality and morbidity following preoperative radiotherapy for hepatocellular carcinoma. HPB (Oxford) 22(5):770-778, 2020. e-Pub 2020. PMID: 31685379.
- Butner JD, Elganainy D, Wang CX, Wang Z, Chen SH, Esnaola NF, Pasqualini R, Arap W, Hong DS, Welsh J, Koay EJ, Cristini V. Mathematical prediction of clinical outcomes in advanced cancer patients treated with checkpoint inhibitor immunotherapy. Sci Adv 6(18):eaay6298, 2020. e-Pub 2020. PMID: 32426472.
- Moningi S, Ajani JA, Badgwell BD, Murphy MB, Ikoma N, Mansfield PF, Ho JC, Suh Y, Crane C, Herman JM, Holliday EB, Koay E, Koong AC, Krishnan S, Minsky B, Smith G, Taniguchi C, Das P. IMRT Reduces Acute Toxicity in Patients Treated with Preoperative Chemoradiation for Gastric Cancer. Adv Radiat Oncol 5(3):369-376, 2020. e-Pub 2020. PMID: 32529130.
- Sen A, Anderson BM, Cazoulat G, McCulloch MM, Elganainy D, McDonald BA, He Y, Mohamed ASR, Elgohari BA, Zaid M, Koay EJ, Brock KK. Accuracy of deformable image registration techniques for alignment of longitudinal cholangiocarcinoma CT images. Med Phys 47(4):1670-1679, 2020. e-Pub 2020. PMID: 31958147.
- Cazoulat G, Elganainy D, Anderson BM, Zaid M, Park PC, Koay EJ, Brock KK. Vasculature-Driven Biomechanical Deformable Image Registration of Longitudinal Liver Cholangiocarcinoma Computed Tomographic Scans. Adv Radiat Oncol 5(2):269-278, 2020. e-Pub 2020. PMID: 32280827.
- Avila S, Smani DA, Koay EJ. Radiation dose escalation for locally advanced unresectable intrahepatic and extrahepatic cholangiocarcinoma. Chin Clin Oncol 9(1):10, 2020. e-Pub 2020. PMID: 32008331.
- Park PC, Choi GW, M Zaid M, Elganainy D, Smani DA, Tomich J, Samaniego R, Ma J, Tamm EP, Beddar S, Koay EJ. Enhancement Pattern Mapping (EPM) Technique for Improving Contrast-to-Noise Ratios (CNRs) and Detectability of Hepatobiliary Tumors on Multiphase Contrast-Enhanced CT (MPCT). Med Phys 47(1):64-74, 2020. e-Pub 2020. PMID: 31449684.
- Bhutani MS, Klapman JB, Tuli R, El-Haddad G, Hoffe S, Wong FCL, Chasen B, Fogelman DR, Lo SK, Nissen NN, Hendifar AE, Varadhachary G, Katz MHG, Erwin WD, Koay EJ, Tamm EP, Singh BS, Mehta R, Wolff RA, Soman A, Cazacu IM, Herman JM. An open-label, single-arm pilot study of EUS-guided brachytherapy with phosphorus-32 microparticles in combination with gemcitabine +/- nab-paclitaxel in unresectable locally advanced pancreatic cancer (OncoPaC-1): Technical details and study protocol. Endosc Ultrasound 9(1):24-30, 2020. e-Pub 2020. PMID: 31670288.
- Zaid M, Elganainy D, Dogra P, Dai A, Widmann L, Fernandes P, Wang Z, Pelaez MJ, Ramirez JR, Singhi AD, Dasyam AK, Brand RE, Park WG, Rahmanuddin S, Rosenthal MH, Wolpin BM, Khalaf N, Goel A, Von Hoff DD, Tamm EP, Maitra A, Cristini V, Koay EJ. Imaging-Based Subtypes of Pancreatic Ductal Adenocarcinoma Exhibit Differential Growth and Metabolic Patterns in the Pre-Diagnostic Period: Implications for Early Detection. Front Oncol 10:596931, 2020. e-Pub 2020. PMID: 33344245.
- Huang H, Zhang Y, Gallegos V, Sorrelle N, Zaid MM, Toombs J, Du W, Wright S, Hagopian M, Wang Z, Hosein AN, Sathe AA, Xing C, Koay EJ, Driscoll KE, Brekken RA. Targeting TGFβR2-mutant tumors exposes vulnerabilities to stromal TGFβ blockade in pancreatic cancer. EMBO Mol Med 11(11):e10515, 2019. e-Pub 2019. PMID: 31609088.
- Moningi S, Ludmir EB, Polamraju P, Williamson T, Melkun MM, Herman JD, Krishnan S, Koay EJ, Koong AC, Minsky BD, Smith GL, Taniguchi C, Das P, Holliday EB. Definitive hyperfractionated, accelerated proton reirradiation for patients with pelvic malignancies. Clin Transl Radiat Oncol 19:59-65, 2019. e-Pub 2019. PMID: 31517071.
- Sanford NN, Pursley J, Noe B, Yeap BY, Goyal L, Clark JW, Allen JN, Blaszkowsky LS, Ryan DP, Ferrone CR, Tanabe KK, Qadan M, Crane CH, Koay EJ, Eyler C, DeLaney TF, Zhu AX, Wo JY, Grassberger C, Hong TS. Protons versus Photons for Unresectable Hepatocellular Carcinoma: Liver Decompensation and Overall Survival. Int J Radiat Oncol Biol Phys 105(1):64-72, 2019. e-Pub 2019. PMID: 30684667.
- Zaid M, Bajaj N, Burrows H, Mathew R, Dai A, Wilke CT, Palasi S, Hergenrother R, Chung C, Fuller CD, Phan J, Gunn GB, Morrison WH, Garden AS, Frank SJ, Rosenthal DI, Andersen M, Otun A, Chambers MS, Koay EJ. Creating customized oral stents for head and neck radiotherapy using 3D scanning and printing. Radiat Oncol 14(1):148, 2019. e-Pub 2019. PMID: 31426824.
- Yu M, Nguyen ND, Huang Y, Lin D, Fujimoto TN, Molkentine JM, Deorukhkar A, Kang Y, San Lucas FA, Fernandes CJ, Koay EJ, Gupta S, Ying H, Koong AC, Herman JM, Fleming JB, Maitra A, Taniguchi CM. Mitochondrial fusion exploits a therapeutic vulnerability of pancreatic cancer. JCI Insight 5, 2019. e-Pub 2019. PMID: 31335325.
- Bhutani MS, Cazacu IM, Luzuriaga Chavez AA, Singh BS, Wong FCL, Erwin WD, Tamm EP, Mathew GG, Le DB, Koay EJ, Taniguchi CM, Minsky BD, Pant S, Tzeng CD, Koong AC, Varadhachary GR, Katz MHG, Wolff RA, Fogelman DR, Herman JM. Novel EUS-guided brachytherapy treatment of pancreatic cancer with phosphorus-32 microparticles: first United States experience. VideoGIE 4(5):223-225, 2019. e-Pub 2019. PMID: 31065616.
- Singhi AD, Koay EJ, Chari ST, Maitra A. Early Detection of Pancreatic Cancer: Opportunities and Challenges. Gastroenterology 156(7):2024-2040, 2019. e-Pub 2019. PMID: 30721664.
- Fujimoto TN, Colbert LE, Huang Y, Molkentine JM, Deorukhkar A, Baseler L, Cruz Bonilla DL, Yu M, Lin D, Gupta S, Cabeceiras PK, Kingsley CV, Tailor RC, Sawakuchi GO, Koay EJ, Piwnica-Worms H, Maitra A, Taniguchi CM. Selective EGLN Inhibition Enables Ablative Radiotherapy and Improves Survival in Unresectable Pancreatic Cancer. Cancer Res 79(9):2327-2338, 2019. e-Pub 2019. PMID: 31043430.
- Yang Z, Chang Y, Brock KK, Cazoulat G, Koay EJ, Koong AC, Herman JM, Park PC, Poenisch F, Li Q, Yang K, Wu G, Anderson B, Ohrt AN, Li Y, Zhu XR, Zhang X, Li H. Effect of setup and inter-fraction anatomical changes on the accumulated dose in CT-guided breath-hold intensity modulated proton therapy of liver malignancies. Radiother Oncol 134:101-109, 2019. e-Pub 2019. PMID: 31005203.
- Chadha AS, Gunther JR, Hsieh CE, Aliru M, Mahadevan LS, Venkatesulu BP, Crane CH, Das P, Herman JM, Koay EJ, Taniguchi C, Holliday EB, Minsky BD, Suh Y, Park P, Sawakuchi G, Beddar S, Odisio BC, Gupta S, Loyer E, Kaur H, Raghav K, Javle MM, Kaseb AO, Krishnan S. Proton beam therapy outcomes for localized unresectable hepatocellular carcinoma. Radiother Oncol 133:54-61, 2019. e-Pub 2019. PMID: 30935582.
- Gulhati P, Prakash L, Katz MHG, Wang X, Javle M, Shroff R, Fogelman D, Lee JE, Tzeng CD, Lee JH, Weston B, Tamm E, Bhosale P, Koay EJ, Maitra A, Wang H, Wolff RA, Varadhachary GR. First-Line Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma. Ann Surg Oncol 26(2):619-627, 2019. e-Pub 2019. PMID: 30324485.
- Bernard V, Kim DU, San Lucas FA, Castillo J, Allenson K, Mulu FC, Stephens BM, Huang J, Semaan A, Guerrero PA, Kamyabi N, Zhao J, Hurd MW, Koay EJ, Taniguchi CM, Herman JM, Javle M, Wolff R, Katz M, Varadhachary G, Maitra A, Alvarez HA. Circulating Nucleic Acids Associate with Outcomes of Patients with Pancreatic Cancer. Gastroenterology 156(1):108-118.e4, 2019. e-Pub 2019. PMID: 30240661.
- Li X, Lee Y, Kang Y, Dai B, Perez MR, Pratt M, Koay EJ, Kim M, Brekken RA, Fleming JB. Hypoxia-induced autophagy of stellate cells inhibits expression and secretion of lumican into microenvironment of pancreatic ductal adenocarcinoma. Cell Death Differ 26(2):382-393, 2019. e-Pub 2019. PMID: 30283082.
- Koay EJ, Lee Y, Cristini V, Lowengrub JS, Kang Y, Lucas FAS, Hobbs BP, Ye R, Elganainy D, Almahariq M, Amer AM, Chatterjee D, Yan H, Park PC, Rios Perez MV, Li D, Garg N, Reiss KA, Yu S, Chauhan A, Zaid M, Nikzad N, Wolff RA, Javle M, Varadhachary GR, Shroff RT, Das P, Lee JE, Ferrari M, Maitra A, Taniguchi CM, Kim MP, Crane CH, Katz MH, Wang H, Bhosale P, Tamm EP, Fleming JB. A visually apparent and quantifiable CT imaging feature identifies biophysical subtypes of pancreatic ductal adenocarcinoma. Clin Cancer Res 24(23):5883-5894, 2018. e-Pub 2018. PMID: 30082477.
- Yu W, Tang C, Hobbs BP, Li X, Koay EJ, Wistuba II, Sepesi B, Behrens C, Rodriguez Canales J, Parra Cuentas ER, Erasmus JJ, Court LE, Chang JY. Development and Validation of a Predictive Radiomics Model for Clinical Outcomes in Stage I Non-small Cell Lung Cancer. Int J Radiat Oncol Biol Phys 102(4):1090-1097, 2018. e-Pub 2018. PMID: 29246722.
- Colbert LE, Rebueno N, Moningi S, Beddar S, Sawakuchi GO, Herman JM, Koong AC, Das P, Holliday EB, Koay EJ, Taniguchi CM. Dose escalation for locally advanced pancreatic cancer: How high can we go?. Adv Radiat Oncol 3(4):693-700, 2018. e-Pub 2018. PMID: 30370371.
- Elganainy D, Holliday EB, Taniguchi CM, Smith GL, Shroff R, Javle M, Raghav K, Kaseb A, Aloia TA, Vauthey JN, Tzeng CD, Herman JM, Koong AC, Krishnan SX, Minsky BD, Crane CH, Das P, Koay EJ. Dose escalation of radiotherapy in unresectable extrahepatic cholangiocarcinoma. Cancer Med 7(10):4880-4892, 2018. e-Pub 2018. PMID: 30152073.
- Milosevic M, Simic V, Milicevic B, Koay EJ, Ferrari M, Ziemys A, Kojic M. Correction function for accuracy improvement of the Composite Smeared Finite Element for diffusive transport in biological tissue systems. Comput Methods Appl Mech Eng 338:97-116, 2018. e-Pub 2018. PMID: 30555187.
- Hunt A, Das P, Minsky BD, Koay EJ, Krishnan S, Herman JM, Taniguchi C, Koong A, Smith GL, Holliday EB. Hyperfractionated abdominal reirradiation for gastrointestinal malignancies. Radiat Oncol 13(1):143, 2018. e-Pub 2018. PMID: 30086784.
- Sharib JM, Fonseca AL, Swords DS, Jaradeh K, Bracci PM, Firpo MA, Hatcher S, Scaife CL, Wang H, Kim GE, Mulvihill SE, Maitra A, Koay EJ, Kirkwood KS. Surgical overtreatment of pancreatic intraductal papillary mucinous neoplasms: Do the 2017 International Consensus Guidelines improve clinical decision making?. Surgery, 2018. e-Pub 2018. PMID: 30170819.
- Grassberger C, Hong TS, Hato T, Yeap BY, Wo JY, Tracy M, Bortfeld T, Wolfgang JA, Eyler CE, Goyal L, Clark JW, Crane CH, Koay EJ, Cobbold M, DeLaney TF, Jain RK, Zhu AX, Duda DG. Differential Association Between Circulating Lymphocyte Populations with Outcome After Radiation Therapy in Subtypes of Liver Cancer. Int J Radiat Oncol Biol Phys 101(5):1222-1225, 2018. e-Pub 2018. PMID: 29859792.
- Kojic M, Milosevic M, Simic V, Koay EJ, Kojic N, Ziemys A, Ferrari M. Multiscale smeared finite element model for mass transport in biological tissue: From blood vessels to cells and cellular organelles. Comput Biol Med 99:7-23, 2018. e-Pub 2018. PMID: 29807251.
- Shiraishi Y, Fang P, Xu C, Song J, Krishnan S, Koay EJ, Mehran RJ, Hofstetter WL, Blum-Murphy M, Ajani JA, Komaki R, Minsky B, Mohan R, Hsu CC, Hobbs BP, Lin SH. Severe lymphopenia during neoadjuvant chemoradiation for esophageal cancer: A propensity matched analysis of the relative risk of proton versus photon-based radiation therapy. Radiother Oncol 128(1):154-160, 2018. e-Pub 2018. PMID: 29248170.
- Wang F, Xia X, Yang C, Shen J, Mai J, Kim HC, Kirui D, Kang Y, Fleming JB, Koay EJ, Mitra S, Ferrari M, Shen H. SMAD4 Gene Mutation Renders Pancreatic Cancer Resistance to Radiotherapy through Promotion of Autophagy. Clin Cancer Res 24(13):3176-3185, 2018. e-Pub 2018. PMID: 29602802.
- Amer AM, Zaid M, Chaudhury B, Elganainy D, Lee Y, Wilke CT, Cloyd J, Wang H, Maitra A, Wolff RA, Varadhachary G, Overman MJ, Lee JE, Fleming JB, Tzeng CW, Katz MH, Holliday EB, Krishnan S, Minsky BD, Herman JM, Taniguchi CM, Das P, Crane CH, Le O, Bhosale P, Tamm EP, Koay EJ. Imaging-based biomarkers: Changes in the tumor interface of pancreatic ductal adenocarcinoma on computed tomography scans indicate response to cytotoxic therapy. Cancer 124(8):1701-1709, 2018. e-Pub 2018. PMID: 29370450.
- Zhao J, Wang H, Hsiao CH, Chow DS, Koay EJ, Kang Y, Wen X, Huang Q, Ma Y, Bankson JA, Ullrich SE, Overwijk W, Maitra A, Piwnica-Worms D, Fleming JB, Li C. Simultaneous inhibition of hedgehog signaling and tumor proliferation remodels stroma and enhances pancreatic cancer therapy. Biomaterials 159:215-228, 2018. e-Pub 2018. PMID: 29331808.
- Hall WA, Heerkens HD, Paulson ES, Meijer GJ, Kotte AN, Knechtges P, Parikh PJ, Bassetti MF, Lee P, Aitken KL, Palta M, Myrehaug S, Koay EJ, Portelance L, Ben-Josef E, Erickson BA. Pancreatic gross tumor volume contouring on computed tomography (CT) compared with magnetic resonance imaging (MRI): Results of an international contouring conference. Pract Radiat Oncol 8(2):107-115, 2018. e-Pub 2018. PMID: 29426692.
- Fang P, Boehling NS, Koay EJ, Bucheit AD, Jakob JA, Settle SH, Brown PD, Davies MA, Sulman EP. Melanoma brain metastases harboring BRAF V600K or NRAS mutations are associated with an increased local failure rate following conventional therapy. J Neurooncol 137(1):67-75, 2018. e-Pub 2018. PMID: 29198052.
- Tang C, Hobbs B, Amer A, Li X, Behrens C, Canales JR, Cuentas EP, Villalobos P, Fried D, Chang JY, Hong DS, Welsh JW, Sepesi B, Court L, Wistuba II, Koay EJ. Development of an Immune-Pathology Informed Radiomics Model for Non-Small Cell Lung Cancer. Sci Rep 8(1):1922, 2018. e-Pub 2018. PMID: 29386574.
- Kojic M, Milosevic M, Kojic N, Koay EJ, Fleming JB, Ferrari M, Ziemys A. Mass release curves as the constitutive curves for modeling diffusive transport within biological tissue. Comput Biol Med 92:156-167, 2018. e-Pub 2018. PMID: 29182964.
- Owens CA, Peterson CB, Tang C, Koay EJ, Yu W, Mackin DS, Li J, Salehpour MR, Fuentes DT, Court LE, Yang J. Lung tumor segmentation methods: Impact on the uncertainty of radiomics features for non-small cell lung cancer. PLoS One 13(10):e0205003, 2018. e-Pub 2018. PMID: 30286184.
- Hong TS, Grassberger C, Yeap BY, Jiang W, Wo JY, Goyal L, Clark JW, Crane CH, Koay EJ, Dima S, Eyler CE, Popescu I, DeLaney TF, Zhu AX, Duda DG. Pretreatment HGF as potential biomarker for susceptibility to radiation-induced liver dysfunction after radiotherapy. NPJ Precis Oncol 2(22):22, 2018. e-Pub 2018. PMID: 30374460.
- Fan J, Wei Q, Koay EJ, Liu Y, Ning B, Bernard PW, Zhang N, Han H, Katz MH, Zhao Z, Hu Y. Chemoresistance Transmission via Exosome-Mediated EphA2 Transfer in Pancreatic Cancer. Theranostics 8(21):5986-5994, 2018. e-Pub 2018. PMID: 30613276.
- Holliday EB, Hunt A, You YN, Chang GJ, Skibber JM, Rodriguez-Bigas MA, Bednarski BK, Eng C, Koay EJ, Minsky BD, Taniguchi C, Krishnan S, Herman JM, Das P. Short course radiation as a component of definitive multidisciplinary treatment for select patients with metastatic rectal adenocarcinoma. J Gastrointest Oncol 8(6):990-997, 2017. e-Pub 2017. PMID: 29299359.
- Kojic M, Milosevic M, Simic V, Koay EJ, Fleming JB, Nizzero S, Kojic N, Ziemys A, Ferrari M. A composite smeared finite element for mass transport in capillary systems and biological tissue. Comput Methods Appl Mech Eng 324:413-437, 2017. e-Pub 2017. PMID: 29200531.
- Borsoi C, Leonard F, Lee Y, Zaid M, Elganainy D, Alexander JF, Kai M, Liu YT, Kang Y, Liu X, Koay EJ, Ferrari M, Godin B, Yokoi K. Gemcitabine enhances the transport of nanovector-albumin-bound paclitaxel in gemcitabine-resistant pancreatic ductal adenocarcinoma. Cancer Lett 403:296-304, 2017. e-Pub 2017. PMID: 28687352.
- Li X, Kang Y, Roife D, Lee Y, Pratt M, Perez MR, Dai B, Koay EJ, Fleming JB. Prolonged exposure to extracellular lumican restrains pancreatic adenocarcinoma growth. Oncogene 36(38):5432-5438, 2017. e-Pub 2017. PMID: 28534517.
- Colbert LE, Moningi S, Chadha A, Amer A, Lee Y, Wolff RA, Varadhachary G, Fleming J, Katz M, Das P, Krishnan S, Koay EJ, Park P, Crane CH, Taniguchi CM. Dose escalation with an IMRT technique in 15 to 28 fractions is better tolerated than standard doses of 3DCRT for LAPC. Adv Radiat Oncol 2(3):403-415, 2017. e-Pub 2017. PMID: 29114609.
- Cloyd JM, Wang H, Egger ME, Tzeng CD, Prakash LR, Maitra A, Varadhachary GR, Shroff R, Javle M, Fogelman D, Wolff RA, Overman MJ, Koay EJ, Das P, Herman JM, Kim MP, Vauthey JN, Aloia TA, Fleming JB, Lee JE, Katz MHG. Association of Clinical Factors with a Major Pathologic Response Following Preoperative Therapy for Pancreatic Ductal Adenocarcinoma. JAMA Surg. e-Pub 2017. PMID: 28700784.
- Katz MHG, Ou FS, Herman JM, Ahmad SA, Wolpin B, Marsh R, Behr S, Shi Q, Chuong M, Schwartz LH, Frankel W, Collisson E, Koay EJ, Hubbard JM, Leenstra JL, Meyerhardt J, O'Reilly E, on Oncology AFCT. Alliance for clinical trials in oncology (ALLIANCE) trial A021501: preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the head of the pancreas. BMC Cancer 17(1):505, 2017. e-Pub 2017. PMID: 28750659.
- Holliday EB, Tao R, Brownlee Z, Das P, Krishnan S, Taniguchi C, Minsky BD, Herman JM, Kaseb A, Raghav K, Conrad C, Vauthey JN, Aloia TA, Chun YS, Crane CH, Koay EJ. Definitive radiation therapy for hepatocellular carcinoma with portal vein tumor thrombus. Clin Transl Radiat Oncol 4:39-45, 2017. e-Pub 2017. PMID: 29594206.
- Yamashita S, Koay EJ, Passot G, Shroff R, Raghav KP, Conrad C, Chun YS, Aloia TA, Tao R, Kaseb A, Javle M, Crane CH, Vauthey JN. Local therapy reduces the risk of liver failure and improves survival in patients with intrahepatic cholangiocarcinoma: A comprehensive analysis of 362 consecutive patients. Cancer 123(8):1354-1362, 2017. e-Pub 2017. PMID: 27984655.
- Heerkens HD, Hall WA, Li XA, Knechtges P, Dalah E, Paulson ES, van den Berg CA, Meijer GJ, Koay EJ, Crane CH, Aitken K, van Vulpen M, Erickson BA. Recommendations for MRI-based contouring of gross tumor volume and organs at risk for radiation therapy of pancreatic cancer. Pract Radiat Oncol 7(2):126-136, 2017. e-Pub 2017. PMID: 28089481.
- Tao R, Tsai CJ, Jensen G, Eng C, Kopetz S, Overman MJ, Skibber JM, Rodriguez-Bigas M, Chang GJ, You YN, Bednarski BK, Minsky BD, Delclos ME, Koay EJ, Krishnan S, Crane CH, Das P. Hyperfractionated accelerated reirradiation for rectal cancer: An analysis of outcomes and toxicity. Radiother Oncol 122(1):146-151, 2017. e-Pub 2017. PMID: 28057329.
- Colbert LE, Cloyd JM, Koay EJ, Crane CH, Vauthey JN. Proton beam radiation as salvage therapy for bilateral colorectal liver metastases not amenable to second-stage hepatectomy. Surgery 161:1543-1548. e-Pub 2017. PMID: 28081954.
- Cloyd JM, Wang H, Overman M, Zhao J, Denbo J, Prakash L, Kim MP, Shroff R, Javle M, Varadhachary GR, Fogelman D, Wolff RA, Koay EJ, Das P, Maitra A, Aloia TA, Vauthey JN, Fleming JB, Lee JE, Katz MH. Influence of Preoperative Therapy on Short- and Long-Term Outcomes of Patients with Adenocarcinoma of the Ampulla of Vater. Ann Surg Oncol. e-Pub 2017. PMID: 28124275.
- Kojic M, Milosevic M, Simic V, Koay EJ, et al. Extension of the composite smeared finite element (CSFE) to include lymphatic system in modeling mass transport in capillary systems and biological tissue. J Serb Soc Comp Mech 11(2):108-119, 2017. e-Pub 2017.
- Wilke C, Zaid M, Chung C, Fuller CD, Abdallah SR, Skinner H, Phan J, Gunn GB, Morrison WH, Garden AS, Frank SJ, Rosenthal DI, Chambers MS, Koay EJ. Design and fabrication of a 3D-printed oral stent for head and neck radiotherapy from routine diagnostic imaging. 3D Printing in Medicine 3(12):1-6, 2017. e-Pub 2017.
- Liang K, Liu F, Fan J, Sun D, Liu C, Lyon CJ, Bernard DW, Li Y, Yokoi K, Katz MH, Koay EJ, Zhao Z, Hu Y. Nanoplasmonic Quantification of Tumor-derived Extracellular Vesicles in Plasma Microsamples for Diagnosis and Treatment Monitoring. Nat Biomed Eng 1, 2017. e-Pub 2017. PMID: 28791195.
- Al-Shamsi HO, Abdel-Wahab R, Hassan MM, Shalaby AS, Dahbour I, Lacin S, Mahvash A, Odisio BC, Murthy R, Avritscher R, Abdelsalam ME, Rashid A, Vauthey JN, Aloia TA, Conrad C, Chun YS, Krishnan S, Das P, Koay EJ, Amin HM, Yao JC, Kaseb AO. Natural History of T1N0M0 Hepatocellular Carcinoma: Large-Scale Study in the United States. Oncology 93(4):233-242, 2017. e-Pub 2017. PMID: 28683459.
- Hanania AN, Bantis LE, Feng Z, Wang H, Tamm EP, Katz MH, Maitra A, Koay EJ. Quantitative imaging to evaluate malignant potential of IPMNs. Oncotarget 7(52):85776-85784, 2016. e-Pub 2016. PMID: 27588410.
- Cloyd JM, Katz MH, Prakash L, Varadhachary GR, Wolff RA, Shroff RT, Javle M, Fogelman D, Overman M, Crane CH, Koay EJ, Das P, Krishnan S, Minsky BD, Lee JH, Bhutani MS, Weston B, Ross W, Bhosale P, Tamm EP, Wang H, Maitra A, Kim MP, Aloia TA, Vauthey JN, Fleming JB, Abbruzzese JL, Pisters PW, Evans DB, Lee JE. Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Experience. J Gastrointest Surg. e-Pub 2016. PMID: 27778257.
- Denbo JW, Bruno ML, Cloyd JM, Prakash L, Lee JE, Kim M, Crane CH, Koay EJ, Krishnan S, Das P, Minsky BD, Varadhachary G, Shroff R, Wolff R, Javle M, Overman MJ, Fogelman D, Aloia TA, Vauthey JN, Fleming JB, Katz MH. Preoperative Chemoradiation for Pancreatic Adenocarcinoma Does Not Increase 90-Day Postoperative Morbidity or Mortality. J Gastrointest Surg. e-Pub 2016. PMID: 27730398.
- Kang Y, Roife D, Lee Y, Lv H, Suzuki R, Ling J, Rios Perez MV, Li X, Dai B, Pratt M, Truty MJ, Chatterjee D, Wang H, Thomas RM, Wang Y, Koay EJ, Chiao PJ, Katz MH, Fleming JB. Transforming Growth Factor-β Limits Secretion of Lumican by Activated Stellate Cells within Primary Pancreatic Adenocarcinoma Tumors. Clin Cancer Res 22(19):4934-4946, 2016. e-Pub 2016. PMID: 27126993.
- Osborne EM, Eng C, Skibber JM, Rodriguez-Bigas MA, Chang GJ, Nancy You YQ, Bednarski BK, Minsky BD, Delclos ME, Koay E, Krishnan S, Crane CH, Das P. Hyperfractionated Accelerated Reirradiation for Patients with Recurrent Anal Cancer Previously Treated With Definitive Chemoradiation. Am J Clin Oncol. e-Pub 2016. PMID: 27755060.
- Cloyd JM, Crane CH, Koay EJ, Das P, Krishnan S, Prakash L, Snyder RA, Varadhachary GR, Wolff RA, Javle M, Shroff RT, Fogelman D, Overman M, Wang H, Maitra A, Lee JE, Fleming JB, Katz MH. Impact of hypofractionated and standard fractionated chemoradiation before pancreatoduodenectomy for pancreatic ductal adenocarcinoma. Cancer 122(17):2671-9, 2016. e-Pub 2016. PMID: 27243381.
- Tom M, Koay EJ, et al. Radiation dose escalation to the tumor-arterial interface of borderline resectable and locally advanced pancreatic cancer. Contemporary Radiation Oncology, 2016. e-Pub 2016.
- Wang Z, Kerketta R, Chuang YL, Dogra P, Butner JD, Brocato TA, Day A, Xu R, Shen H, Simbawa E, Al-Fhaid AS, Mahmoud SR, Curley SA, Ferrari M, Koay EJ, Cristini V. Theory and Experimental Validation of a Spatio-temporal Model of Chemotherapy Transport to Enhance Tumor Cell Kill. PLoS Comput Biol 12(6):e1004969, 2016. e-Pub 2016. PMID: 27286441.
- Zuo M, Rashid A, Wang Y, Jain A, Li D, Behari A, Kapoor VK, Koay EJ, Chang P, Vauthey JN, Li Y, Espinoza JA, Roa JC, Javle M. RNA sequencing-based analysis of gallbladder cancer reveals the importance of the liver X receptor and lipid metabolism in gallbladder cancer. Oncotarget 7(23):35302-12, 2016. e-Pub 2016. PMID: 27167107.
- Xu R, Zhang G, Mai J, Deng X, Segura-Ibarra V, Wu S, Shen J, Liu H, Hu Z, Chen L, Huang Y, Koay E, Liu J, Ensor JE, Blanco E, Liu X, Ferrari M, Shen H. An injectable nanoparticle generator enhances delivery of cancer therapeutics. Nat Biotechnol 34(4):414-8, 2016. e-Pub 2016. PMID: 26974511.
- Tao R, Krishnan S, Bhosale PR, Javle MM, Aloia TA, Shroff RT, Kaseb AO, Bishop AJ, Swanick CW, Koay EJ, Thames HD, Hong TS, Das P, Crane CH. Ablative Radiotherapy Doses Lead to a Substantial Prolongation of Survival in Patients With Inoperable Intrahepatic Cholangiocarcinoma: A Retrospective Dose Response Analysis. J Clin Oncol 34(3):219-26, 2016. e-Pub 2016. PMID: 26503201.
- Rios Perez MV, Dai B, Koay EJ, Wolff RA, Fleming JB. Regression of Stage IV Pancreatic Cancer to Curative Surgery and Introduction of a Novel Ex-Vivo Chemosensitivity Assay. Cureus 7(12):e423, 2015. e-Pub 2015. PMID: 26848412.
- Koay EJ, Ferrari M. Transport Oncophysics in silico, in vitro, and in vivo. Preface. Phys Biol 11(6):060201, 2014. e-Pub 2014. PMID: 25426742.
- Koay EJ, Baio FE, Ondari A, Truty MJ, Cristini V, Thomas RM, Chen R, Chatterjee D, Kang Y, Zhang J, Court L, Bhosale PR, Tamm EP, Qayyum A, Crane CH, Javle M, Katz MH, Gottumukkala VN, Rozner MA, Shen H, Lee JE, Wang H, Chen Y, Plunkett W, Abbruzzese JL, Wolff RA, Maitra A, Ferrari M, Varadhachary GR, Fleming JB. Intra-tumoral heterogeneity of gemcitabine delivery and mass transport in human pancreatic cancer. Phys Biol 11(6):065002, 2014. e-Pub 2014. PMID: 25427073.
- Kirui DK, Koay EJ, Guo X, Cristini V, Shen H, Ferrari M. Tumor vascular permeabilization using localized mild hyperthermia to improve macromolecule transport. Nanomedicine 10(7):1487-96, 2014. e-Pub 2014. PMID: 24262998.
- Walker GV, Awan M, Tao R, Koay EJ, Boehling NS, Grant JD, Sittig DF, Gunn GB, Garden AS, Phan J, Morrison WH, Rosenthal DI, Mohamed AS, Fuller CD. Prospective randomized double-blind study of atlas-based organ-at-risk autosegmentation-assisted radiation planning in head and neck cancer. Radiother Oncol 112(3):321-5, 2014. e-Pub 2014. PMID: 25216572.
- Koay EJ, Truty MJ, Cristini V, Thomas RM, Chen R, Chatterjee D, Kang Y, Bhosale PR, Tamm EP, Crane CH, Javle M, Katz MH, Gottumukkala VN, Rozner MA, Shen H, Lee JE, Wang H, Chen Y, Plunkett W, Abbruzzese JL, Wolff RA, Varadhachary GR, Ferrari M, Fleming JB. Transport properties of pancreatic cancer describe gemcitabine delivery and response. J Clin Invest 124(4):1525-36, 2014. e-Pub 2014. PMID: 24614108.
- Lee Y, Koay EJ, Zhang W, Qin L, Kirui DK, Hussain F, Shen H, Ferrari M. Human equilibrative nucleoside transporter-1 knockdown tunes cellular mechanics through epithelial-mesenchymal transition in pancreatic cancer cells. PLoS One 9(10):e107973, 2014. e-Pub 2014. PMID: 25314577.
- Pascal J, Ashley CE, Wang Z, Brocato TA, Butner JD, Carnes EC, Koay EJ, Brinker CJ, Cristini V. Mechanistic modeling identifies drug-uptake history as predictor of tumor drug resistance and nano-carrier-mediated response. ACS Nano 7(12):11174-82, 2013. e-Pub 2013. PMID: 24187963.
- Pascal J, Bearer EL, Wang Z, Koay EJ, Curley SA, Cristini V. Mechanistic patient-specific predictive correlation of tumor drug response with microenvironment and perfusion measurements. Proc Natl Acad Sci U S A 110(35):14266-71, 2013. e-Pub 2013. PMID: 23940372.
- Xu R, Huang Y, Mai J, Zhang G, Guo X, Xia X, Koay EJ, Qin G, Erm DR, Li Q, Liu X, Ferrari M, Shen H. Multistage vectored siRNA targeting ataxia-telangiectasia mutated for breast cancer therapy. Small 9(9-10):1799-808, 2013. e-Pub 2013. PMID: 23293085.
- Koay EJ, Lege D, Mohan R, Komaki R, Cox JD, Chang JY. Adaptive/nonadaptive proton radiation planning and outcomes in a phase II trial for locally advanced non-small cell lung cancer. Int J Radiat Oncol Biol Phys 84(5):1093-100, 2012. e-Pub 2012. PMID: 22543217.
- Koay EJ, Teh BS, Paulino AC, Butler EB. Treatment trends and outcomes of small-cell carcinoma of the bladder. Int J Radiat Oncol Biol Phys 83(1):64-70, 2012. e-Pub 2012. PMID: 22019246.
- Koay EJ, Teh BS, Paulino AC, Butler EB. A Surveillance, Epidemiology, and End Results analysis of small cell carcinoma of the bladder: epidemiology, prognostic variables, and treatment trends. Cancer 117(23):5325-33, 2011. e-Pub 2011. PMID: 21567387.
- Koay EJ, Smith B. Commentary on “Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancer. Breast Diseases: A Year Book Quarterly(22):197-199, 2011. e-Pub 2011.
- Koay EJ, Athanasiou KA. Development of serum-free, chemically defined conditions for human embryonic stem cell-derived fibrochondrogenesis. Tissue Eng Part A 15(8):2249-57, 2009. e-Pub 2009. PMID: 19231974.
- Ofek G, Willard VP, Koay EJ, Hu JC, Lin P, Athanasiou KA. Mechanical characterization of differentiated human embryonic stem cells. J Biomech Eng 131(6):061011, 2009. e-Pub 2009. PMID: 19449965.
- Koay EJ, Athanasiou KA. Hypoxic chondrogenic differentiation of human embryonic stem cells enhances cartilage protein synthesis and biomechanical functionality. Osteoarthritis Cartilage 16(12):1450-6, 2008. e-Pub 2008. PMID: 18541445.
- Hoben GM, Koay EJ, Athanasiou KA. Fibrochondrogenesis in two embryonic stem cell lines: effects of differentiation timelines. Stem Cells 26(2):422-30, 2008. e-Pub 2008. PMID: 18032702.
- Koay EJ, Ofek G, Athanasiou KA. Effects of TGF-beta1 and IGF-I on the compressibility, biomechanics, and strain-dependent recovery behavior of single chondrocytes. J Biomech 41(5):1044-52, 2008. e-Pub 2008. PMID: 18222457.
- Koay EJ, Hoben GM, Athanasiou KA. Tissue engineering with chondrogenically differentiated human embryonic stem cells. Stem Cells 25(9):2183-90, 2007. e-Pub 2007. PMID: 17540854.
- Shieh AC, Koay EJ, Athanasiou KA. Strain-dependent recovery behavior of single chondrocytes. Biomech Model Mechanobiol 5(2-3):172-9, 2006. e-Pub 2006. PMID: 16506017.
- Koay EJ, Shieh AC, Athanasiou KA. Creep indentation of single cells. J Biomech Eng 125(3):334-41, 2003. e-Pub 2003. PMID: 12929237.
Invited Articles
- Srivastava S, Koay EJ, Borowsky AD, DeMarzo AM, Ghosh S, Wagner PD, Kramer BS. Cancer overdiagnosis: a biological challenge and clinical dilemma. Nature Reviews Cancer(19):349-358, 2019. e-Pub 2019.
- Singhi A, Koay EJ, Maitra A, Chari S. Early Detection of Pancreatic Cancer: Opportunities and Challenges. Gastroenterology 156(7):2024-2040, 2019. e-Pub 2019.
- Koay EJ, Owen D, Das P. Radiation-induced liver disease and modern radiotherapy. Semin Radiat Oncol 28(4):321-331, 2018. e-Pub 2018. PMID: 30309642.
- Ng SP, Koay EJ. Current and emerging radiotherapy strategies for pancreatic adenocarcinoma: stereotactic, intensity modulated and particle radiotherapy. Ann Pancreat Cancer 1, 2018. e-Pub 2018. PMID: 30198024.
- Zhao J, Koay EJ, Li T, Wen X, Li C. A hindsight reflection on the clinical studies of poly(l-glutamic acid)-paclitaxel. Wiley Interdiscip Rev Nanomed Nanobiotechnol 10(3):e1497, 2018. e-Pub 2018. PMID: 28895304.
- Fonseca AL, Kirkwood K, Kim MP, Maitra A, Koay EJ. Intraductal Papillary Mucinous Neoplasms of the Pancreas: Current Understanding and Future Direction for Stratification of Malignancy Risk. Pancreas 47(3):272-279, 2018. e-Pub 2018. PMID: 29424809.
- Koay EJ, Hall W, Park PC, Erickson B, Herman JM. The role of imaging in the clinical practice of radiation oncology for pancreatic cancer. Abdom Radiol (NY) 43(2):393-403, 2018. e-Pub 2018. PMID: 29110053.
- Bhosale P, Cox V, Faria S, Javadi S, Viswanathan C, Koay EJ, Tamm E. Genetics of pancreatic cancer and implications for therapy. Abdom Radiol (NY) 43(2):404-414, 2018. e-Pub 2018. PMID: 29177925.
- Javadi S, Karbasian N, Bhosale P, de Castro Faria S, Le O, Katz MH, Koay EJ, Tamm EP. Imaging findings of recurrent pancreatic cancer following resection. Abdom Radiol (NY) 43(2):489-496, 2018. e-Pub 2018. PMID: 29198001.
- Koay EJ, Odisio BC, Javle M, Vauthey JN, Crane CH. Management of unresectable intrahepatic cholangiocarcinoma: how do we decide among the various liver-directed treatments?. Hepatobiliary Surg Nutr 6(2):105-116, 2017. e-Pub 2017. PMID: 28503558.
- Koay EJ, Amer AM, Baio FE, Ondari AO, Fleming JB. Toward stratification of patients with pancreatic cancer: Past lessons from traditional approaches and future applications with physical biomarkers. Cancer Lett 381(1):237-43, 2016. e-Pub 2016. PMID: 26806807.
- Crane CH, Koay EJ. Solutions that enable ablative radiotherapy for large liver tumors: Fractionated dose painting, simultaneous integrated protection, motion management, and computed tomography image guidance. Cancer 122(13):1974-86, 2016. e-Pub 2016. PMID: 26950735.
- Cabrera AR, Kirkpatrick JP, Fiveash JB, Shih HA, Koay EJ, Lutz S, Petit J, Chao ST, Brown PD, Vogelbaum M, Reardon DA, Chakravarti A, Wen PY, Chang E. Radiation therapy for glioblastoma: Executive summary of an American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline. Pract Radiat Oncol 6(4):217-25, 2016. e-Pub 2016. PMID: 27211230.
- Brocato T, Dogra P, Koay EJ, Day A, Chuang YL, Wang Z, Cristini V. Understanding Drug Resistance in Breast Cancer with Mathematical Oncology. Curr Breast Cancer Rep 6(2):110-120, 2014. e-Pub 2014. PMID: 24891927.
- Woodward W, Koay EJ, Takiar V. Radiation therapy for inflammatory breast cancer: Technical considerations and diverse clinical scenarios. Breast Cancer Management 3:43-52, 2014. e-Pub 2014.
- Koay EJ, Sulman EP. Management of brain metastasis: past lessons, modern management, and future considerations. Curr Oncol Rep 14(1):70-8, 2012. e-Pub 2012. PMID: 22071681.
Other Articles
- Chang, E, Sherry, AD, Liermann, J, Abdollahi, A, Tzeng, CD, Tang, C, Aguilera, T, Koay, EJ, Das, P, Koong, A, Pant, S, Ludmir, EB Evolving Paradigms in the Treatment of Oligometastatic Pancreatic Ductal Adenocarcinoma. Journal of Gastrointestinal Cancer 56(1), 2025. PMID: 39827280.
- Chhabra, A, Amos, R, Simone, C, Kaiser, A, Perles, LA, Giap, H, Hallemeier, C, Johnson, JE, Lin, H, Wroe, AJ, Diffenderfer, ES, Wolfgang, JA, Sakurai, H, Lu, HM, Hong, TS, Koay, EJ, Terashima, K, Vitek, P, Rule, WG, Apisarnthanarax, SJ, Badiyan, S, Molitoris, JK, Chuong, MD, Nichols, RC Proton Beam Therapy for Pancreatic Tumors. International Journal of Radiation Oncology Biology Physics 122(1):19-30, 2025. PMID: 39761799.
- Dudzinski SO, Newman NB, McIntyre J, Engineer R, Sanford NN, Wo JY, Seong J, Guha C, Chang DT, Hong TS, Dawson LA, Koay EJ, Ludmir EB Emerging evidence-based role for external-beam radiation therapy in hepatocellular carcinoma. Lancet Gastroenterol Hepatol 10(4):387-398, 2025. PMID: 39993402.
- Smith, L, Mahoney, DW, Bamlet, WR, Yu, F, Liu, S, Goggins, M, Darabi, S, Majumder, S, Wang, QL, Cote, G, Demeure, MJ, Zhang, Z, Srivastava, S, Chawla, A, Izmirlian, G, Olson, JE, Wolpin, BM, Genkinger, JM, Zaret, KS, Brand, RE, Koay, EJ, Oberg, AL Early detection of pancreatic cancer. Pancreatology 24(8):1265-1279, 2024. PMID: 39516175.
- Li, X, Lee, Y, Kang, Y, Dai, B, Perez, MV, Pratt, M, Koay, EJ, Kim, M, Brekken, RA, Fleming, JB RETRACTED ARTICLE. Cell death and differentiation 31(11):1576, 2024. PMID: 39322749.
- Gok Yavuz, B, Datar, S, Chamseddine, SM, Mohamed, Y, Lapelusa, M, Lee, SS, Hu, Z, Koay, EJ, Tran Cao, HS, Jalal, P, Daniel-MacDougall, CR, Hassan, MM, Duda, DG, Amin, H, Kaseb, A The Gut Microbiome as a Biomarker and Therapeutic Target in Hepatocellular Carcinoma. Cancers 15(19), 2023. PMID: 37835569.
- Koay, EJ, Javle, M, Belknap, M, Derasari, S, Roach, MA, Ludmir, EB What Role Does Radiotherapy Play in the Molecular Era for Intrahepatic Cholangiocarcinoma?. Cancer Journal (United States) 29(5):272-278, 2023. PMID: 37796645.
- Syed M, Cagely M, Dogra P, Hollmer L, Butner JD, Cristini V, Koay EJ Immune-checkpoint inhibitor therapy response evaluation using oncophysics-based mathematical models. Wiley Interdiscip Rev Nanomed Nanobiotechnol 15(2):e1855, 2023. PMID: 36148978.
- Tovar, DR, Rosenthal, MH, Maitra, A, Koay, EJ Potential of artificial intelligence in the risk stratification for and early detection of pancreatic cancer. Artificial Intelligence Surgery 3(1):14-26, 2023. PMID: 37124705.
- Singh BS, Cazacu IM, Deza CA, Rigaud BS, Saftoiu A, Gruionu G, Guionu L, Brock KK, Koay EJ, Herman JM, Bhutani MS Image Fusion Involving Real-Time Transabdominal or Endoscopic Ultrasound for Gastrointestinal Malignancies: Review of Current and Future Applications. Diagnostics (Basel) 12(12), 2022. PMID: 36553225.
- Ardeshna, DR, Cao, T, Rodgers, B, Onongaya, C, Jones, D, Chen, W, Koay, EJ, Krishna, SG Recent advances in the diagnostic evaluation of pancreatic cystic lesions. World journal of gastroenterology 28(6):624-634, 2022. PMID: 35317424.
- Bagley AF, Ludmir EB, Maitra A, Minsky BD, Li Smith G, Das P, Koong AC, Holliday EB, Taniguchi CM, Katz MHG, Tamm EP, Wolff RA, Overman MJ, Patel S, Kim MP, Tzeng CD, Ikoma N, Bhutani MS, Koay EJ NBTXR3, a first-in-class radioenhancer for pancreatic ductal adenocarcinoma: Report of first patient experience. Clin Transl Radiat Oncol 33:66-69, 2022. PMID: 35097226.
- Bent EH, Wehrenberg-Klee E, Koay EJ, Goyal L, Wo JY Integration of Systemic and Liver-Directed Therapies for Locally Advanced Hepatocellular Cancer: Harnessing Potential Synergy for New Therapeutic Horizons. J Natl Compr Canc Netw 19(5):567-576, 2021. PMID: 34030132.
- Gok Yavuz B, Hasanov E, Lee SS, Mohamed YI, Curran MA, Koay EJ, Cristini V, Kaseb AO Current Landscape and Future Directions of Biomarkers for Immunotherapy in Hepatocellular Carcinoma. J Hepatocell Carcinoma 8:1195-1207, 2021. PMID: 34595140.
- Hall WA, Small C, Paulson E, Koay EJ, Crane C, Intven M, Daamen LA, Meijer GJ, Heerkens HD, Bassetti M, Rosenberg SA, Aitken K, Myrehaug S, Dawson LA, Lee P, Gani C, Chuong MD, Parikh PJ, Erickson BA Magnetic Resonance Guided Radiation Therapy for Pancreatic Adenocarcinoma, Advantages, Challenges, Current Approaches, and Future Directions. Front Oncol 11:628155, 2021. PMID: 34046339.
- He K, Barsoumian HB, Bertolet G, Verma V, Leuschner C, Koay EJ, Ludmir EB, Hsu E, Pisipati E, Voss TA, Puebla-Osorio N, Cortez MA, Welsh JW Novel Use of Low-Dose Radiotherapy to Modulate the Tumor Microenvironment of Liver Metastases. Front Immunol 12:812210, 2021. PMID: 34975924.
- Dogra P, Butner JD, Nizzero S, Ruiz Ramírez J, Noureddine A, Peláez MJ, Elganainy D, Yang Z, Le AD, Goel S, Leong HS, Koay EJ, Brinker CJ, Cristini V, Wang Z Image-guided mathematical modeling for pharmacological evaluation of nanomaterials and monoclonal antibodies. Wiley Interdiscip Rev Nanomed Nanobiotechnol 12(5):e1628, 2020. PMID: 32314552.
- Chang DT, Koay EJ, Herman JM, Hong TS, Das P Abdominal and Pelvic Reirradiation for Recurrent Gastrointestinal Cancers. Semin Radiat Oncol 30(3):232-237, 2020. PMID: 32503788.
- Pereira SP, Oldfield L, Ney A, Hart PA, Keane MG, Pandol SJ, Li D, Greenhalf W, Jeon CY, Koay EJ, Almario CV, Halloran C, Lennon AM, Costello E Early detection of pancreatic cancer. Lancet Gastroenterol Hepatol 5(7):698-710, 2020. PMID: 32135127.
- Machicado JD, Koay EJ, Krishna SG Radiomics for the Diagnosis and Differentiation of Pancreatic Cystic Lesions. Diagnostics (Basel) 10(7), 2020. PMID: 32708348.
- Srivastava S, Koay EJ, Borowsky AD, De Marzo AM, Ghosh S, Wagner PD, Kramer BS Cancer overdiagnosis: a biological challenge and clinical dilemma. Nat Rev Cancer 19(6):349-358, 2019. PMID: 31024081.
- Fonseca AL, Cristini V, Maitra A, Koay EJ The dilemma of over diagnosis of pancreatic cysts, Adjacent Government, 2017.
- Fonseca AL, Cristini V, Maitra A, Koay EJ Identifying pancreatic cysts that might turn into cancer, Adjacent Government, 2017.
- Koay EJ Commentary on: Hif1a Deletion Reveals Pro-Neoplastic Function of B Cells in Pancreatic Neoplasia. Faculty of 1000, 2016.
- Koay EJ Commentary on: Outcomes after Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma. Faculty of 1000, 2015.
- Koay EJ, Wang Z, Cristini V Combining biology with physics to solve the cancer problem, Special Report in Adjacent Government, 2015.
- Martin GV, Koay EJ, Cristini V The Mathematical Relationship between the Immune System and Cancer and its Implications for Cancer Therapy, Special Report in Adjacent Government, 2015.
- Koay EJ Commentary on: Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Faculty of 1000, 2015.
- Koay EJ Leadership Message: Eugene Koay, MD, PhD. Pancan.org, 2015.
- Koay EJ Commentary on: Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma. Faculty of 1000, 2015.
- Cristini V, Koay EJ, Wang Z Predicting Cancer Treatment Outcome using Physics, Special Report in Adjacent Government, 2015.
- Cristini V, Koay EJ, Wang Z Feature in International Innovation, 2015: Taking Cancer Out of the Equation, 2015.
Abstracts
- Sharib J, Wimmer K, Fonseca AL, Shen Y, Koay EJ, Maitra A, Esserman L, Ozanne E, Kirkwood KS. Sensitivity and Specificity Required for Diagnostics or Management Guidelines for Intraductal Papillary Mucinous Neoplasms to Be Cost-Effective. Journal of the American College of Surgeons 227(4):S180-S181, 2201. e-Pub 2201.
- Sohn A, Katz M Prakash L, Chatterjee D, Wang H, Kim M, Tzeng CW, Lee J, Ikoma N, Rashid A, Wolff RA, Zhao D, Koay E, Mitra A, Wang H. Integrated Pathologic Score Effectively Stratifies Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant therapy and Pancreaticoduodenectomy. Laboratory Investigation 102(SUPPL 1):1233-1233, 2022. e-Pub 2022.
- Sun L, Sohn A, Katz M, Prakash L, Wang H, Kim M, Tzeng CW, Lee J, Ikoma N, Rashid A, Wolff RA, Zhao D, Koay E, Maitra A, Wang H. A Single Center Clinicopathological Study of Comparison of Pancreatic Acinar Cell Carcinoma and its Mixed Differentiations. Modern Pathology 35(Suppl 2):1234-1234, 2022. e-Pub 2022.
- Tong YT, Lai ZS, Katz M, Prakash L, Wang H, Chatterjee D, Kim M, Tzeng CW, Lee J, Ikoma N Rashid A, Wolff RA, Zhao D, Koay E, Maitra A, Wang HM. Pathologic Prognosticators for Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Therapy. Modern Pathology 35(Suppl 2):1236-1236, 2022. e-Pub 2022.
- Sohn A, Katz M, Prakash L, Chatterjee D, Wang H, Kim M, Tzeng CW, Lee J, Ikoma N, Rashid A, Wolff RA, Zhao D, Koay E, Maitra A, Wang H. Integrated Pathologic Score Effectively Stratifies Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant therapy and Pancreaticoduodenectomy. Modern Pathology 35(Suppl 2):1233-1233, 2022. e-Pub 2022.
- Sun L, Sohn A, Katz M, Prakash L, Wang H, Kim M, Tzeng CW, Lee J, Ikoma N, Rashid A, Wolff RA, Zhao D, Koay E, Maitra A, Wang H. A Single Center Clinicopathological Study of Comparison of Pancreatic Acinar Cell Carcinoma and its Mixed Differentiations. Laboratory Investigation 102(SUPPL 1):1234-1234, 2022. e-Pub 2022.
- Tong YT, Lai ZS, Katz M, Prakash L, Wang H, Chatterjee D, Kim M, Tzeng CW, Lee J, Ikoma N Rashid A, Wolff RA, Zhao D, Koay E, Maitra A, Wang HM. Pathologic Prognosticators for Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Therapy. Laboratory Investigation 102(SUPPL 1):1236-1236, 2022. e-Pub 2022.
- Jaoude JA, De B, Jimenez HRN, Upadhyay R, Taniguchi CM, Koay EJ, Ludmir EB. "Super massive" intrahepatic cholangiocarcinoma: Potential role of radiation therapy. J Clin Oncol 40(4), 2022. e-Pub 2022.
- Hernandez S, Lourenco AL, Kirimli E, York TJ, Glencer A, Conroy PC, Craik CS, Koay EJ, Behr SC, Kirkwood K. Using Quantitative Radiomics and Cyst Fluid Biomarkers to Predict Pancreatic Cyst Type. Journal of the American College of Surgeons 233(5):S156-S156, 2021. e-Pub 2021.
- Rooney M, De B, Corrigan K, Gonzalez GN, Das P, Taniguchi C, Smith G, Minsky B, Koong A, Koay E, Ludmir E, Messick C, You N, Change G, Westney O, Morris V, Holliday E. Dosimetric Parameters Associated with Long-Term Patient-Reported Quality of Life Following Definitive Chemoradiation for Anal Cancer. American Journal of Clinical Oncology-Cancer Clinical Trials 44(10):S145-S145, 2021. e-Pub 2021.
- De B, Abu-Gheida I, Patel A, Ng S, Zaid M, Thunshelle C, Elganainy D, Javle M, Raghav K, Lee S, Vauthey JN, Tzeng CW, Cao HT, Ludmir E, Minsky B, Smith G, Holliday E, Taniguchi C, Koong A, Das P, Koay E. Benchmarking Outcomes After Ablative Radiotherapy for Molecularly Characterized Unresectable Intrahepatic Cholangiocarcinoma. American Journal of Clinical Oncology-Cancer Clinical Trials 44(10):S6-S7, 2021. e-Pub 2021.
- Zaid M, Bajaj N, Mathew R, Roach M, Agrawal A, Wilke C, Chung C, Fuller C, Gunn G, Phan J, Morrison W, Garden A, Frank S, Rosenthal D, Cardoso R, Wesson RA, Otun A, Chambers M, Koay E. A Prospective Trial Evaluating Patient Reported Outcomes (PROs) of Oral Stents Fabricated Using Intraoral Scanning (IOS) and 3D Printing for Head and Neck Cancer Patients Receiving Radiotherapy (RT). American Journal of Clinical Oncology-Cancer Clinical Trials 44(10):S91-S91, 2021. e-Pub 2021.
- Holliday E, Kahn Z, Rooney M, Das P, Chang G, Peacock O, Sawakuchi G, Ludmir E, Koay E, Smith G, Taniguchi C, Minsky B, Koong A. Intraoperative Radiation After Pelvic Short Course Radiotherapy for Patients with Locally Advanced Rectal Adenocarcinoma with Involved or Threatened Circum-ferential Resection Margin. American Journal of Clinical Oncology-Cancer Clinical Trials 44(10):S53-S53, 2021. e-Pub 2021.
- Kim MP, Li XQ, Deng JY, Zhang Y, Dai BB, Allton K, Hughes T, Siangco C, Augustine J, Kang Y, McDaniel JM, Xiong SB, Koay E, McAllister F, Bristow C, Heffernan T, Maitra A, Liu B, Barton M, Wasylischen A, Fleming J, Lozano G. Mutant p53 and oncogenic KRAS converge on CREB1 to drive pancreatic cancer metastasis. Cancer Research 81(13), 2021. e-Pub 2021.
- Srinivasan S, rose J, Yao WT, Seth S, Peoples M, Machado A, Li CY, Ho IL, Lee JJ, Guerrera PA, Kim E, Syed M, Daniele J, Deem AK, Kim M, Bristow CA, Koay E, Genovese G, Viale A, Heffernan TP, Maitra A, Hart T, Carugo A, Draetta G. Diversity across the pancreatic ductal adenocarcinoma disease spectrum revealed by network-anchored functional genomics. Cancer Research 81(13), 2021. e-Pub 2021.
- Kim MP, Li XQ, Deng JY, Zhang Y, Dai BB, Allton K, Hughes T, Siangco C, Augustine J, Kang Y, McDaniel JM, Xiong SB, Koay E, McAllister F, Bristow C, Heffernan T, Maitra A, Liu B, Barton M, Wasylischen A, Fleming J, Lozano G. Full Text Options 6 of 43 Mutant p53 and oncogenic KRAS converge on CREB1 to drive pancreatic cancer metastasis. Cancer Research 81(13), 2021. e-Pub 2021.
- Taku N, You YN, Ludmir EB, Smith GL, Rodriguez-Bigas MA, Chang GJ, Skibber JM, Koong AC, Minsky BD, Holliday EB, Koay EJ, Dasari A, Taniguchi CM, Bednarski BK, Morris V, Overman MJ, Kopetz S, Raghav KPS, Das P. Clinical outcomes following definitive treatment of young-onset, locally advanced rectal cancer: A single institution experience. J Clin Oncol 39(15), 2021. e-Pub 2021.
- Kouzy R, Lin D, El Alam MB, Jaoude JA, Smith GL, EJ <, Minsky BD, Das P, Holliday EB, Klopp A, Taniguchi CM, Colbert LE. Association of the anorectal microbiome and patient-reported gastrointestinal outcomes in patients with anal cancer. J Clin Oncol 39(15), 2021. e-Pub 2021.
- Lee SS, Cao HST, Tzeng CWD, Metwalli Z, Koay E, Ludmir EB, Chun YS, Chun SG, Javle MM. Clinical outcomes analysis of TP53-mutated advanced and metastatic biliary tract cancers. J Clin Oncol 39(15), 2021. e-Pub 2021.
- Thunshelle C, Zaid M, Herman J, Koay E. Blood-based and Imaging-Based Biomarker Outcomes for Patients with Pancreatic Ductal Adenocarcinoma Treated with Different Radiotherapy Techniques. Int J Radiat Oncol Biol Phys 108(2):E34-E34, 2020. e-Pub 2020.
- Koay E, Bajaj N, Elhammali A, Shiao J, Taniguchi C, Holliday E, Smith G, Das P, Minsky B, Koong A, Herman J, Tzeng CW, Vauthey J, Kopetz S. Clinical Associations of Treatment Failure After Radiation Therapy for Colorectal Liver Metastases. Int J Radiat Oncol Biol Phys 108(2):E53-E54, 2020. e-Pub 2020.
- Shobaki D, Bhutani M, Mathew G, Aliru M, Bokhari R, Koay E, Taniguchi C, Herman J. How to Improve Enrollment onto GI Radiation Oncology Clinical Trials: Lessons Learned From a Brachytherapy Trial for Newly Diagnosed Locally Advanced Pancreatic Cancer. Int J Radiat Oncol Biol Phys 108(2):E55-E56, 2020. e-Pub 2020.
- De B, Ng SP, Mohan R, Kaseb A, Raghav K, Lee S, Minsky B, Das P, Holliday E, Smith G, Taniguchi C, Herman J, Koong A, Koay E. Outcomes with Proton and Photon Radiotherapy for Unresectable Hepatocellular Carcinoma. Int J Radiat Oncol Biol Phys 108(2):E35-E36, 2020. e-Pub 2020.
- Kouzy R, Jaoude JA, Lin D, El Alam MB, Minsky BD, Koay EJ, Das P, Holliday EB, Klopp AH, Colbert LE, Taniguchi CM. Patient-reported gastrointestinal outcomes in patients with anal cancer. J Clin Oncol 38(15), 2020. e-Pub 2020.
- Kim BJ, Panettieri E, Kawaguchi Y, Kang HC, Cox V, Koay E, Raghav K, Kaseb A, Vega EA, Mizuno T, Pant S, Javle M, Vauthey JN. Arterial enhancement pattern predicts survival in patients with both unresectable and resected intrahepatic cholangiocarcinoma. Gastroenterology 158(6):S1496-S1497, 2020. e-Pub 2020.
- Wei DG, Zaid M, Koay E, Katz MH, Kim M, Lee J, Varadhachary G, Wolff RA, Bhosale P, Maitra A, Rashid A, Wang HM. Clinicopathological Correlation of Radiologic Measurement of the Post-Therapy Tumor Size for Pancreatic Ductal Adenocarcinoma. Laboratory Investigation 100(SUPPL 1):1682-1683, 2020. e-Pub 2020.
- Wei DG, Zaid M, Koay E, Katz MH, Kim M, Lee J, Varadhachary G, Wolff RA, Bhosale P, Maitra A Rashid A, Wang HM. Clinicopathological Correlation of Radiologic Measurement of the Post-Therapy Tumor Size for Pancreatic Ductal Adenocarcinoma. Modern Pathology 33(SUPPL 2):1682-1683, 2020. e-Pub 2020.
- Colina A, Raghav KPS, Katz MHG, Das P, Ikoma N, Koay E, Thomas JV, Tzeng CWD, Wolff RA, Overman MJ. Pattern of recurrence after curative resection of stage I-III duodenal adenocarcinoma. J Clin Oncol 38(4), 2020. e-Pub 2020.
- Mizrahi JD, Moningi S, Nogueras-Gonzalez GM, Wolff RA, Javle MM, Varadhachary GR, Ho L, Fogelman DR, Raghav KP, Overman MJ, Crane CH, Herman JM, Koong AC, Koay EJ, Rogers JE, Pant S. Maintenance chemotherapy after chemoradiation in patients with locally advanced pancreatic cancer. Cancer Research 79(24), 2019. e-Pub 2019.
- Cazacu IM, Singh BS, Martin R, Slagowski J, Beddar S, Koay E, Taniguchi C, Herman J, Bhutani MS. Endoscopic Ultrasound-Guided Fiducial Placement for Stereotactic Body Radiation Therapy in Patients with Pancreatic Adenocarcinoma. Amer J Gastroenterology 114(S):A539-S540, 2019. e-Pub 2019.
- Abu-Gheida I, Patel A, Zaid M, Elganainy D, Javle MM, Raghav KPS, Vauthey JN, Aloia TA, Tzeng CWD, Minsky BD, Smith GL, Holliday EB, Taniguchi CM, Koong A, Krishnan S, Herman JM, Das P, Crane CH, Koay EJ. Outcomes and patterns of failures after hypofractionated radiation therapy for intrahepatic cholangiocarcinoma. J Clin Oncol 37(15), 2019. e-Pub 2019.
- Hughes T, Prakash LR, Maitra A, Bhutani MS, McAllister F, Ross WA, Weston BR, Koay E, Wang HM, Lee J, Vauthey JN, Lee JE, Vauthey JN, Lee JE, Aloia T, Tzeng CW, Katz M, Kim MP. Pancreatic duct caliber does not reliably distinguish malignant from premalignant main duct IPMNS. Gastroenterology 156(6):S1444-S1445, 2019. e-Pub 2019.
- Zaid M, Bajaj N, Bathew R, Chung C, Wilke C, Fuller CD, Andersen MR, Gunn B, Morrison W, Garden AS, Frank SJ, Rosenthal D, Adegbenga OO, Chambers MS, Koay E. A Prospective Trial Evaluating Patient Reported Outcomes of Customized Oral Stents for Head and Neck (HN) Radiotherapy (RT) Using 3D Printing and Traditional Methods. Int J Radiat Oncol Biol Phys 103(5):E35-E36, 2019. e-Pub 2019.
- Aliru M, Bernard V, Ng SP, Moningi S, Lindsay D, Berlind C, Ahern C, Holmes A, Edwards T, Smith B, Taniguchi C, Koay E, Das P, Holliday E, Herman J. Data Analytics Platform for Outcome Comparison of Patients Treated for Primary Pancreatic Cancer Using SBRT vs Conventional RT. Int J Radiat Oncol Biol Phys 103(5):E51-E51, 2019. e-Pub 2019.
- Moningi S, Aliru M, Lin D, Avila S, Smani D, Koay E, Taniguchi C, Das P, Smith G, Holliday E, Cazacu I, Singh B, Bhutani M, Koong A, Herman J. Does Fiducial Marker Placement Prior to SBRT Increase the Risk of Metastatic Disease in Patients with Unresectable Pancreatic Cancer?. Int J Radiat Oncol Biol Phys 103(5):E31-E31, 2019. e-Pub 2019.
- Moningi S, Ajani J, Badgwell B, Murphy M, Ikoma N, Ho J, Holliday E, Herman J, Minsky B, Kay E, Koong A, Krishnan S, Smith G, Taniguchi C, Das P. Can IMRT Reduce Lymphopenia in Patients Treated with Preoperative Chemoradiation for Gastric Cancer?. Int J Radiat Oncol Biol Phys 103(5):E11-E11, 2019. e-Pub 2019.
- Wang C, Elganainy D, Zaid M, Butner J, Cristini V, Koay E. Mass Transport Model of Radiation Response: Calibration and Application to Chemoradiation for Pancreatic Cancer. Int J Radiat Oncol Biol Phys 103(5):E48-E49, 2019. e-Pub 2019.
- Moningi S, Ajani JA, Badgwell BD, Mansfield PF, Murphy MAB, Ikoma N, Ho J, Suh Y, Holliday EB, Herman JM, Minsky BD, Koay EJ, Koong A, Krishnan S, Smith GL, Taniguchi CM, Das P. The effect of IMRT on acute toxicity in patients with gastric cancer treated with preoperative chemoradiation. J Clin Oncol 37(4), 2019. e-Pub 2019.
- Fan J, Wei Q, Koay EJ, Liu Y, Zhao Z, Hu Y. Exosomal EphA2 transmits chemoresistance and predicts pancreatic cancer patient responses to therapy. Cancer Research 78(13), 2018. e-Pub 2018.
- Bernard V, Kim DU, San Lucas FA, Castillo J, Allenson K, Mulu FC, Stephens BM, Huang J, Koay E, Taniguchi CM, Javle M, Wolff RA, Katz MH, Varadhachary GR, Alvarez HA, Maitra A. Circulating nucleic acids as biomarkers of prognosis and chemorefractory status in metastatic pancreatic cancer. Cancer Research 78(13), 2018. e-Pub 2018.
- Solis LM, Uraoka N, Parra ER, Shen Y, Wei W, Jiang M, Mno B, Affolter K, Scaife CL, Yip-Schneider MT, Schmidt CM, Firpo M, Mulvihill S, Koay EJ, Wang HM, Wistuba II, Maitra A, Sen S. Characterization of immune profiling of pancreatic intraductal papillary mucinous neoplasm using multiplex immunofluorescence and image analysis approaches. Cancer Research 78(13), 2018. e-Pub 2018.
- Hunt A, Das P, Minsky BD, Koay EJ, Krishnan S, Herman JM, Taniguchi C, Koong A, Smith GL, Holliday EB. Hyperfractionated Abdominal Reirradiation for Gastrointestinal Malignancies. Int J Radiat Oncol Biol Phys 101(2):E27-E27, 2018. e-Pub 2018.
- Abdel-Wahab R, Ali SM, Borad MJ, Shroff RT, Kwong L, Vauthey JN, Koay EJ, Zuo MX, Rashid A, Schrock AB, Ross JS, Bekaii-Saab TS, Javle MM. Variations in DNA repair genomic alterations and tumor mutation burden in biliary tract cancer (BTC) subtypes. J Clin Oncol 36(4), 2018. e-Pub 2018.
- Gulhati P, Prakash L, Katz MHG, Wang XM, Javle MM, Shroff RT, Fogelman DR, Lee JE, Tzeng CWD, Lee JH, Weston B, Tamm EP, Bhosale P, Koay EJ, Maitra A, Wang H, Wolff RA, Varadhachary GR. First line gemcitabine and nab-paclitaxel chemotherapy for localized pancreatic ductal adenocarcinoma. J Clin Oncol 36(4), 2018. e-Pub 2018.
- Hester RH, Taniguchi CM, Holliday EB, Koay EJ, Das P, Minsky BD, Rashid A, Mehdizadeh A, Ohinata A, Messick C, You YN, Chang GJ, Bednarski B, Rodriguez-Bigas MA, Skibber JM, Wolff RA, Eng C, Morris VK. CEA as a pharmacodynamic biomarker for metastatic anal cancer. J Clin Oncol 36(4), 2018. e-Pub 2018.
- Ng SP, Liu A, Tao RD, Holliday EB, Brownlee Z, Kaseb AO, Raghav KPS, Vauthey JN, Minsky BD, Herman JM, Das P, Taniguchi CM, Krishnan S, Crane CH, Hong TS, Mohan R, Koay EJ. Lymphopenia and outcomes of patients with unresectable hepatocellular carcinoma treated with radiotherapy. J Clin Oncol 36(4), 2018. e-Pub 2018.
- Zaid M, Chaudhury B, Varadhachary G, Katz MH, Herman JM, Tamm EP, Koay EJ. Discovery and validation of a quantitative stromal-associated imaging biomarker of pancreatic ductal adenocarcinoma. 2018 GI ASCO Symposium, 2018. e-Pub 2018.
- Abdel-Wahab R, Shroff R, Vauthey JN, Koay EJ, Ali S, Kwong L, Zuo MX, Rashid A, Javle M. DNA repair genetic aberrations and tumor mutation burden in biliary tract cancers. Journal for Immunotherapy of Cancer 5(Suppl 2), 2017. e-Pub 2017.
- Sharib J, Fonseca AL, Kim GE, Koay EJ, Maitra A, Kirkwood KS. Which Clinical Features Predict Overtreatment for Intraductal Papillary Mucinous Neoplasms?. Journal of the American College of Surgeons 225(4):S140-S140, 2017. e-Pub 2017.
- Lu Y, Tang C, Liao ZX, Jeter M, Hahn S, Das P, Koay E, Herman J, Nguyen QN. Long-Term Outcome and Toxicity of Stereotactic Ablative Body Radiotherapy (SABR) for Liver Metastases From Solid Tumors. Int J Radiat Oncol Biol Phys 98(2):E14-E14, 2017. e-Pub 2017.
- Moningi S, Amer A, Colbert L, Lee Y, Wolff R, Varadhachary G, Das P, Herman JM, Taniguchi C, Fleming JB, Katz MH, Crane C, Le O, Bhosale P, Tamm E, Koay EJ. Can Imaging-Based Biomarkers of Pancreatic Cancer be Used to Select Patients for Dose-Escalated Radiotherapy?. Int J Radiat Oncol Biol Phys 98(2):E7-E7, 2017. e-Pub 2017.
- Wilke C, Amer A, Elganainy D, Bhosale P, Le O, Lee Y, Cloyd J, Wang H, Herman J, Taniguchi C, Rhim A, Fleming JB, Maitra A, Wolff RA, Varadhachary G, Lee JE, Katz MP, Tamm EP, Koay EJ. Tumor interface stability on CT imaging is an early marker of response to cytotoxic therapy in pancreatic ductal adenocarcinoma. J Clin Oncol 35(4), 2017. e-Pub 2017.
- Lee Y, Cristini V, Varadhachary G, Katz M, Wang H, Bhosale P, Tamm E, Fleming J, Koay EJ. Quantitative CT analysis identifies biophysical subtypes of pancreatic ductal adenocarcinoma. 2016 ASTRO Annual Meeting, 2016. e-Pub 2016.
- Tang C, Amer A, Hobbs B, Li X, Behrens C, Parra Cuentas E, Rodriguez J, Chang J, Hong D, Welsh J, Wistuba I, Koay EJ. Pathology-based NSCLC radiomics signature describing the local tumor immune environment: discovery and validation. 2016 ASTRO Annual Meeting, 2016. e-Pub 2016.
- Amer A, Tao R, Kang H, Chun Y, Vauthey J, Javle M, Kaseb A, Crane C, Koay EJ. Quantitative European Association for the Study of Liver (qEASL) as an Early Biomarker of Response after Radiotherapy for Intrahepatic Cholangiocarcinoma. 2016 ASTRO Annual Meeting, 2016. e-Pub 2016.
- Moningi S, Amer A, Colbert L, Lee Y, Hall W, Erickson B, Varadhachary G, Das P, Taniguchi C, Fleming J, Katz M, Crane C, Koay EJ. A CT imaging feature of pancreatic cancer as a predictive biomarker for escalated dose radiotherapy. 2016 ASTRO Annual Meeting, 2016. e-Pub 2016.
- Amer A, Lee Y, Moningi S, Varadhachary G, Katz M, Tamm E, Fleming J, Koay EJ. Validation of an Imaging-based Classification of Patients with Locally Advanced and Borderline Resectable Pancreatic Cancer. 2016 RSNA Annual Meeting, 2016. e-Pub 2016.
- Koay EJ, et al. Changes in mass transport as an early biomarker of response in pancreatic cancer. 2014 American Radium Society Annual Meeting, 2014. e-Pub 2014.
- Koay EJ, et al. Novel CT-derived biophysical markers of human pancreatic adenocarcinoma quantitatively describe gemcitabine delivery and response. 2013 American Radium Society Annual Meeting, 2013. e-Pub 2013.
Book Chapters
- Manzar, G, Abi Jaoude, J, Taniguchi, C, Koong, A, Koay, EJ, Ludmir, EB. Radiation Therapy for Pancreatic Cancer, 37-55, 2023.
- Thunshelle, CP, Koay, EJ, Hill, C, Alfano, CM, Herman, JM. Patient reported outcomes and quality of life, 351-373, 2022.
- Holliday, EB, Koay, EJ, Taniguchi, C, Koong, A. Management of resectable and borderline resectable disease, 153-171, 2022.
- Thomas, JJ, Douglas, JE, Koay, EJ. Imaging-based biomarkers for pancreatic cancer, 229-240, 2022.
- Douglas, JE, Koay, EJ. Radiation Therapy, 389-395, 2022.
- Hill, C, Koay, EJ, Herman, JM. Locoregional Approaches to Colorectal Liver Metastasis – Radiation Options, 211-231, 2022.
- Douglas JE, Koay EJ. Imaging-based biomarkers for pancreatic cancer. In: Pancreatic Cancer: A Multidisciplinary Approach. Springer Publishing, 2022.
- Douglas JE, Koay EJ. Radiation Therapy. In: Colorectal Liver Metastasis. Springer Publishing, 2021.
- Kirichenko A, Koay EJ, EJ, Hasan S, Crane CH. Stereotactic Body Radiotherapy with Functional Treatment Planning. In: Hepatocellular Carcinoma and Alternate Fractionation in Radiotherapy – Paradigm Change. Springer Publishing, 2018.
- Koay EJ, Athanasiou K. Articular cartilage biomechanics, mechanobiology, and tissue engineering. In: Biomechanics Systems. World Scientific Publishing, 2007.
Books (edited and written)
- Cristini V, Koay EJ, Wang Z. An Introduction to Physical Oncology. CRC Press, 2017.
Letters to the Editor
- Tino, R, Roach, MA, Fuentes, GD, Agrawal, A, Zaid, M, Cooper, DJ, Bajaj, N, Lin, R, Xiao, L, Mayo, LL, Wiederhold, LR, Shah, SJ, Tate, MK, Chronowski, G, Reddy, JP, Mezera, M, Mann, JM, Augspurger, ME, Otun, AO, Chambers, MS, Lee, A, Koay, EJ. Response to recent comments on “Development and clinical implementation of a digital workflow utilizing 3D-printed oral stents for patients with head and neck cancer receiving radiotherapy”. Oral Oncology 162, 2025.
- Smith GL, Das P, Herman JM, Koay EJ, Koong AC, Grossberg A, Ludmir E. Comparing Ablative Modalities for Hepatocellular Carcinoma: Cautions in Interpreting Big Data. J Clin Oncol 36: JCO2018785428, 2018.
- Crane CH, Koay EJ. Reply to another solution that enables ablative radiotherapy for large liver tumors: Percutaneous interstitial high-dose rate brachytherapy. Cancer 122: 2766-7, 2016.
Selected Presentations & Talks
Local Presentations
- 2020. Oncophysics of cancer progression and therapy, in vivo and in silico. Conference. MD Anderson. Houston, TX, US.
- 2018. “Clinical application of immune-related transport oncophysics in pancreatic cancer”. Conference. Houston Methodist Research Institute. Houston, TX, US.
- 2017. “Radiation treatment updates for gastrointestinal cancers”. Conference. MD Anderson Cancer Center. Houston, TX, US.
- 2017. “Functional imaging guidance of radiation treatment in patients with impaired liver function”. Conference. MD Anderson Cancer Center. Houston, TX, US.
- 2016. “Biophysical subtypes of pancreatic cancer and their differential responses to therapy”. Conference. MD Anderson Cancer Center. Houston, TX, US.
- 2016. “Advances in Radiation Oncology for Hepatobiliary and Pancreatic Cancers”. Conference. UT Medical School at Houston. Houston, TX, US.
- 2016. Precision Medicine in an Era of Advanced Quantitative Imaging”. Conference. MD Anderson Cancer Center. Houston, TX, US.
- 2016. “A Challenging Case of Cellulitis and Myositis”. Conference. MD Anderson Cancer Center. Houston, TX, US.
- 2015. “Understanding the Physical Microenvironment of Cancer with Transport Oncophysics”. Conference. MD Anderson Cancer Center. Houston, TX, US.
- 2015. “Imaging-based biomarkers in hepatobiliary and pancreatic cancers”. Conference. MD Anderson Cancer Center. Houston, TX, US.
- 2015. “Simulation and Treatment of GI Cancers”. Conference. MD Anderson Cancer Center. Houston, TX, US.
- 2012. “CT-derived biophysical markers describe gemcitabine-based therapy delivery and response”. Conference. MD Anderson Cancer Center. Houston, TX, US.
National Presentations
- 2023. Multi-institutional PDAC Early Detection Efforts through the NCI Early Detection Research Network: Radiomics, AI, and Federated Learning. Invited. PRECEDE Annual Meeting. New York, NY, US.
- 2023. Integrating radiomics, AI, and biomarkers into early detection strategies. Invited. Hirshberg Symposium of Annual Pancreatic Association Meeting. San Diego, CA, US.
- 2023. Radiomics for pancreatic cancer and cholangiocarcinoma. Invited. 5th Annual CCA Summit, Scottsdale, AZ, 9/2023. Scottsdale, AZ, US.
- 2023. Management of localized biliary tract cancers. Invited. Aptitude Health symposium on biliary tract cancers, US.
- 2023. Radiation dose escalation for pancreatic and hepatobiliary cancers. Invited. Varian Scientific Symposium (virtual), US.
- 2023. Phase 1 study of NBTXR3 activated by radiotherapy for locally advanced or borderline resectable pancreatic ductal adenocarcinoma. Invited. talk for Nanoparticle Enhanced Radiotherapy Workshop, European COST Action (virtual), US.
- 2022. “Next generation imaging. Invited. Annual PancreasFest Conference, University of Pittsburgh, PA, US.
- 2022. “Imaging for Pancreatic Cancer. Invited. Annual Cold Spring Harbor Short Course on Pancreatic Cancer. Long Island, NY, US.
- 2022. Applications of Machine Learning and Radiomics for Pancreatic Cancer: Early Detection and Therapeutic Interventions. Invited. Annual Neurofibromatosis Conference. Philadelphia, PA, US.
- 2022. Combining quantitative imaging and mechanistic mathematical models to predict outcomes to cytotoxic and immune-oncology therapies. Invited. European Society for Molecular Imaging. Virtual, US.
- 2022. Imaging and artificial intelligence for early detection of pancreatic cancer. Invited. American Association for Cancer Research (AACR) Annual Meeting. New Orleans, LA, US.
- 2022. A federated model for multi-site studies: application for early detection of pancreatic cancer. Invited. Digestive Diseases Week Annual Meeting. San Diego, CA, US.
- 2022. Hepatobiliary cancers. Invited. Northwestern University Radiation Oncology Department (Virtual), US.
- 2022. Updates on hypofractionated RT for intrahepatic cholangiocarcinoma (Virtual). Invited. NCI HCC Interest Group, US.
- 2022. Radiation therapy for hepatocellular carcinoma. Invited. Baylor College of Medicine Hepatology and Liver Transplantation Conference (Virtual), US.
- 2021. Radiomic classifications for pancreatic cancer and intrahepatic cholangiocarcinoma: biophysical subtypes with therapeutic implications. Invited. NCI GI Interest Group (Virtual), US.
- 2021. “External beam radiation therapy for primary liver cancers: An ASTRO clinical practice guideline. Invited. ASTRO Annual Meeting (Virtual), US.
- 2021. Quantitative imaging of pancreatic cancer from macroscopic to microscopic scales. Invited. AACR Annual Meeting (virtual), US.
- 2021. Unmet imaging needs in the early diagnosis of pancreatic cancer. Invited. Digestive Diseases Week Annual Meeting, US.
- 2021. Challenges and opportunities for radiomics, AI, and federated learning for early detection of pancreatic ductal adenocarcinoma. Invited. RSNA Annual Meeting (Virtual), US.
- 2020. Differential growth patterns and metabolic effects of imaging-based subtypes of PDAC. Invited. Society of Abdominal Radiology Monthly Meeting, US.
- 2020. Personalization of early detection strategies using oncophysics. Invited. University of California Pancreatic Cancer Consortium Annual Meeting, US.
- 2020. “Quantitative imaging and mechanistic mathematical modeling to predict cytotoxic and immunotherapy responses in cancer. Invited. Astrazeneca Grand Rounds, US.
- 2020. Current and emerging areas for imaging of pancreatic cancer. Invited. Cold Spring Harbor Annual Pancreatic Cancer Symposium, NY, US.
- 2019. Imaging of Pancreatic Cancer. Invited. Lustgarten Foundation Therapeutics Advisory Group Meeting. New York, NY, US.
- 2019. Radiation dose escalation for cholangiocarcinoma and pancreatic cancer. Invited. Visiting Professor at Allegheny General Hospital. Pittsburg, PA, US.
- 2019. Quantitative Imaging Response Metrics for Hepatobiliary and Pancreatic Cancers. Conference. AAPM Annual Meeting Educational Session on AI for Assessing Therapy Response. San Antonio, TX, US.
- 2019. Enhancement Pattern Mapping for Earlier Detection of Liver Cancers. Invited. NCI Liver Fibrosis to Cancer meeting. Bethesda, MD, US.
- 2018. Immunologic properties of biophysical subtypes of pancreatic cancer: implications for therapeutic selection. Invited. Plenary talk. Boston, MA, US.
- 2018. Changes in Mass Transport as a Biomarker of Response in Pancreatic Ductal Adenocarcinoma. Invited. American Pancreatic Association Young Investigators Symposium. Miami, FL, US.
- 2018. CT-based radiomics for hepatobiliary and pancreatic cancer. Invited. Post-ASTRO MD Anderson Symposium. Houston, TX, US.
- 2018. Imaging for early detection of pancreatic cancer: Visualizing the hallmarks. Invited. Alliance for Pancreatic Cancer Consortia. Bethesda, MD, US.
- 2018. “Morphological Phenotype of PDAC on CT: Radiation Oncology Perspective”. Invited. Society of Abdominal Radiology Disease Focus Panel on Pancreatic Cancer, Monthly WebEx Meeting, US.
- 2018. "Imaging and Early Detection". Invited. NCI EDRN Scientific Workshop, Co-Chair, Session IV. Bethesda, MD, US.
- 2018. "Multi-parametric Image Processing for Early Detection of Cancer". Invited. NCI EDRN Scientific Workshop. Bethesda, MD, US.
- 2018. Image processing methods to improve diagnostic evaluation. Invited. Stand Up to Cancer Pancreatic Cancer Mini-Summit. Philadelphia, PA, US.
- 2018. Changes in Mass Transport as a Biomarker of Response in Pancreatic Ductal Adenocarcinoma. Invited. American Pancreatic Association Annual Meeting. Miami, FL, US.
- 2018. Imaging of pancreatic cancer for early detection: visualizing the Hallmarks. Conference. Alliance for Pancreatic Cancer Consortia. Bethesda, MD, US.
- 2017. “Educase module: Liver SBRT”. Invited. American Radium Society Annual Meeting. Colorado Springs, CO, US.
- 2017. “Radiomics of GI cancers”. Invited. Stanford University Symposium on Contemporary Topics in Radiation Oncology. Palo Altos, CA, US.
- 2017. “Imaging-based subtypes of pancreatic cancer”, http://xtalks.com/Imaging-based-Subtypes-of-Pancreatic-Cancer.html. Invited. Definiens XTalks Webinar, US.
- 2017. “Bridging genotypes to phenotypes”, Discussion Session I: Technologies and Standardized Methodologies. Invited. NCI PreCancer Atlas Think Tank Meeting. Rockvolle, MD, US.
- 2017. “Changes in mass transport as a biomarker of response in pancreatic cancer”. Invited. NRG Semi-Annual Meeting. Houston, TX, US.
- 2017. “Pancreatic Cancer: Perspective of Radiation Oncology”. Invited. Society of Abdominal Radiology Disease-Focused Panel on Pancreatic Cancer Monthly WebEx Meeting, US.
- 2016. “The Center for Immunotherapeutic Transport Oncophysics, Project 2”. Invited. Joint Meeting of the Cancer Systems Biology Consortium and Physical Sciences Oncology Network. Rockville, MD, US.
- 2016. “Applications of quantitative imaging for risk stratification and early detection of pancreatic cancer”. Invited. NCI EDRN Orientation Meeting – Radiomics Session. Bethesda, MD, US.
- 2016. Moderator for “Scientific Session 31: GI – Anorectal”. Invited. ASTRO Annual Meeting. Boston, MA, US.
- 2016. “Imaging-based risk stratification and treatment response in pancreatic cancer”. Invited. Alliance Meeting – Imaging Working Group (Via WebEx). Chicago, IL, US.
- 2016. "Imaging biomarkers of pancreatic cancer: we see them, so now what?". Invited. NCI Alliance for Pancreatic Cancer Consortia. Rockville, MD, US.
- 2016. “Patient-specific image analysis for early detection and risk stratification”. Invited. NCI Molecular Characterization Laboratory Steering Committee Meeting. San Francisco, CA, US.
- 2015. "ASTRO Glioblastoma Guidelines: Key Question 1 – When is radiotherapy indicated after biopsy/resection of newly diagnosed glioblastoma and how does systemic therapy modify its effects?”. Conference. American Society for Radiation Oncology Annual Meeting. San Antonio, TX, US.
- 2015. “Predicting outcomes of primary and metastatic pancreatic cancer using principles of mass transport”. Invited. AAPM Annual Meeting. Anaheim, CA, US.
- 2015. “Biophysical subtypes of human pancreatic cancer” MBI Workshop number 5: Treatment, Clinical Trials, Resistance. Invited. The Ohio State University. Columbus, OH, US.
- 2014. “Changes in mass transport as a biomarker of response in human pancreatic cancer”. Conference. American Radium Society Annual Meeting, St. John.
- 2014. “Integrated imaging analysis and mechanistic mathematical oncology in human pancreatic cancer”. Invited. IEEE EMBC Annual Meeting. Chicago, IL, US.
- 2013. “Mass transport and outcome in human pancreatic adenocarcinoma”. Conference. NCI-PSOC Annual Summer Retreat. Bethesda, MD, US.
- 2007. “Tissue engineering with chondrogenically-differentiated human embryonic stem cells”. Conference. Annual MD/PhD Student Conference. Keystone, CO, US.
- 2007. “Effects of IGF-I and TGF-beta1 on the strain-dependent recovery behavior of single chondrocytes”. Conference. BMES Annual Meeting. Los Angeles, CA, US.
- 2007. “Effects of serum on human embryonic stem cell-derived fibrochondrogenesis”. Conference. BMES Annual Meeting. Los Angeles, CA, US.
- 2006. “Articular cartilage self-assembly with human embryonic stem cells”. Conference. NSF IGERT Project Meeting. Arlington, VA, US.
- 2001. “Development of a Novel Method for Creep Indentation of Single Chondrocytes”. Conference. BMES Annual Meeting. Durham, NC, US.
International Presentations
- 2023. Progress in radiotherapy for cholangiocarcinoma. Invited. 6th Annual Asia- Pacific Cholangiocarcinoma Conference. Mumbai, IN.
- 2023. PIONEER Panc: an adaptive trial platform for new and emerging therapies in localized pancreatic cancer. Invited. DAVA Oncology Global Summit for GI Malignancies, BM.
- 2023. A phase I trial of NBTXR3 and radiation therapy for patients with locally advanced or borderline resectable pancreatic cancer. Invited. first annual DAVA oncology Global Summit for GI Malignancies, BM.
- 2023. Ablative radiation for patients with intrahepatic cholangiocarcinoma. Invited. DAVA Oncology Global Summit for GI Malignancies, BM.
- 2023. Imaging-based subtypes of pancreatic cancer: molecular, pathological correlations with implications of early detection and selection for treatments. Invited. 5th International Conference on Medical Imaging and Therapeutics. Boston, US.
- 2022. Leveraging AI, radiomics, and big data tools for pancreatic cancer and cholangiocarcinoma. Invited. Australasian GI Trials Group Annual Meeting (Breakfast session). Melbourne, AU.
- 2022. Dose escalation and translational research for pancreatic and hepatobiliary cancers. Invited. Australasian GI Trials Group Annual Meeting. Melbourne, AU.
- 2022. Clinical evidence for dose escalation for pancreatic and hepatobiliary cancers. Invited. Grand Rounds at Austin Health Hospital. Melbourne, AU.
- 2019. Radiation therapy for hepatobiliary cancers. Invited. Mumbai Conference for Pancreatic and Hepatobiliary Cancers, US.
- 2018. "Enhancement pattern mapping of multi-parametric contrast-enhanced images for early detection of cancer". Invited. US/Japan Workshop for Cancer Research. Tokyo, JP.
- 2018. "Acceleration of collaborative research between Japan and US". Invited. US/Japan Workshop for Cancer Research - Biomarker Discovery for Early Cancer Detection - Co-Chair, Session 2. Tokyo, JP.
- 2018. Dose escalated radiation therapy for pancreatic cancer. Invited. MR Linac Consortium Annual Meeting. Toronto, CA.
- 2017. “Ablative radiation therapy for intrahepatic cholangiocarcinoma”. Invited. Chulalongkorn University Hospital, 1st Asia Pacific Cholangiocarcinoma Conference, TH.
- 2016. “Radiomics in Radiation Oncology: Lessons from Astrophyscis”. Invited. Korean Society for Radiation Oncology Annual Meeting.
Formal Peers
- 2024. Radiation dose escalation for pancreatic and hepatobiliary cancer: How can we better select patients?. Visiting, US.
- 2023. Phase I study of NBTXR3 activated by radiotherapy for locally advanced or borderline resectable pancreatic ductal adenocarcinoma. Visiting, US.
- 2022. Clinical evidence for dose escalation for pancreatic and hepatobiliary cancers. Visiting, US.
- 2022. Hepatobiliary cancers. Visiting, US.
- 2020. Oncophysics of cytotoxic and immune-based therapies. Invited. San Antonio, TX, US.
- 2016. Physics-based approaches to classify and detect pancreatic cancer. Invited. Omaha, NE, US.
- 2015. Biophysical subtypes of human pancreatic cancer MBI Workshop number 5: Treatment, Clinical Trials, Resistance. Invited. Columbus, OH, US.
Grant & Contract Support
Date: | 2024 - 2029 |
Title: | Multi-Omic Early Detection of Pancreatic Cancer |
Funding Source: | Pancreatic Cancer of North America |
Role: | PI |
Date: | 2024 - 2028 |
Title: | Magnetic nanocluster based combination immunotherapy for cancer metastasis |
Funding Source: | NIH/NCI |
Role: | Multiple- Principal Investigator |
Date: | 2024 - 2029 |
Title: | High-Precision Proton Therapy |
Funding Source: | NIH/NCI |
Role: | Co-PI |
Date: | 2023 - 2028 |
Title: | Risk Stratification for and Early Detection of Liver Cancer |
Funding Source: | NIH/NCI |
Role: | Multiple- Principal Investigator-MDACC |
ID: | 2U01CA230997-06 |
Date: | 2023 - 2025 |
Title: | Modeling Tumor Immune Micro Environment (TIME) Architecture |
Funding Source: | Society for Immunotherapy of Cancer (SITC) |
Role: | Co-I |
Date: | 2023 - 2028 |
Title: | Hyperion CCA: A phase II randomized trial of systemic therapy with or without adaptive liver-directed radiation therapy for patients with M1 intrahepatic cholangiocarcinoma |
Funding Source: | Varian Medical Systems INC |
Role: | PI |
Date: | 2022 - 2027 |
Title: | Strategic Alliance with Artidis |
Funding Source: | Artidis AG |
Role: | PI |
ID: | CS2023-00061744-TK |
Date: | 2022 - 2027 |
Title: | The MD Anderson/Johns Hopkins Cholangiocarcinoma ROBIN Center: Project 1 - Radiomic Subtypes and Resistance to Radiation |
Funding Source: | NIH |
Role: | Project Co-Lead |
ID: | U54CA274281 |
Date: | 2022 - 2027 |
Title: | The MD Anderson/Johns Hopkins Cholangiocarcinoma ROBIN Center: Administrative Core |
Funding Source: | NIH |
Role: | Administrative Co-Core Lead |
ID: | U54CA274281 |
Date: | 2022 - 2027 |
Title: | The MD Anderson/Johns Hopkins Cholangiocarcinoma ROBIN Center: Molecular Characterization Trial (MCT) |
Funding Source: | NIH |
Role: | Co-I |
ID: | U54CA274281 |
Date: | 2022 - 2027 |
Title: | Paul Calabresi Clinical Oncology Award |
Funding Source: | NIH/NCI |
Role: | Mentor |
ID: | 2 K12 CA088084 |
Date: | 2022 - 2026 |
Title: | Novel Metabolomics and Radiomics for Predicting HCC Risk |
Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
Role: | Co-I |
ID: | RP220119 |
Date: | 2021 - 2026 |
Title: | Integrating patient-specific clinical and biological factors towards individualizing utilization of proton and photon radiation therapy. Project 1: Understanding normal tissue toxicity to identify patients most likely to benefit from proton therapy |
Funding Source: | NIH/NCI |
Role: | Multiple- Principal Investigator |
ID: | 5P01CA261669-03 |
Date: | 2021 - 2026 |
Title: | Integrating patient-specific clinical and biological factors towards individualizing utilization of proton and photon radiation therapy. Project 1: Understanding normal tissue toxicity to identify patients most likely to benefit from proton therapy |
Funding Source: | Massachusetts General Hospital/NIH |
Role: | Project Co-Lead |
ID: | P01CA261669 |
Date: | 2021 - 2026 |
Title: | Medical Students Summer in Oncology at Anderson Research (Med Students SOAR) program |
Funding Source: | NIH |
Role: | Preceptor |
Date: | 2021 - 2024 |
Title: | Integrating Radiomics and Genomics to Improve the Clinical Assessment of Pancreatic Cysts and Early Detection of Pancreatic Cancer |
Funding Source: | Department of Defense (DOD) |
Role: | Multiple- Principal Investigator |
ID: | W81XWH-21-1-0710 |
Date: | 2021 - 2022 |
Title: | Development and Validation of an Imaging-Based Deep Learning Neural Network Model to Predict Tumor-Related Liver Failure in Unresectable Intrahepatic Cholangiocarcinoma |
Funding Source: | Radiological Society of North America (RSNA) |
Role: | Mentor |
Date: | 2020 - 2025 |
Title: | Radiosensitivity of Immune Cells as a Function of Dose, Linear Energy Transfer and Ion Species and its Impact on Incidence and Severity of Radiation Induced Immune System Suppression |
Funding Source: | NIH/NCI |
Role: | Co-I |
ID: | R01CA256853 |
Date: | 2020 - 2025 |
Title: | Imaging and liquid biopsy-based monitoring of pancreatic cancer to select for local therapies |
Funding Source: | NIH/NCI |
Role: | PI |
ID: | R01CA249069 |
Date: | 2020 - 2025 |
Title: | The Texas-Louisiana Alliance to Study Chronic Pancreatitis, Diabetes and Pancreatic Cancer |
Funding Source: | NIH/NCI |
Role: | Co-I |
ID: | U01DK126365 |
Date: | 2020 - 2025 |
Title: | Multiparametric image processing for risk stratification and early detection of hepatocelllar carcinoma |
Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
Role: | PI |
Date: | 2020 - 2025 |
Title: | Targeting Focal Adhesion Kinase to Improve RT-Induced Tumor Immunity |
Funding Source: | NIH/NCI |
Role: | Co-I |
ID: | 5R01CA248917-03 |
Date: | 2020 - 2021 |
Title: | Translating Mitochondrial Fusion as a Novel Therapeutic Strategy against Pancreatic Cancer |
Funding Source: | The Mark Foundation for Cancer Research |
Role: | Co-I |
Date: | 2019 - 2020 |
Title: | Pancreatic Moonshot Flagship 2 |
Funding Source: | MD Anderson Cancer Center |
Role: | Co-I |
Date: | 2019 - 2021 |
Title: | MD Anderson Cancer Center SPORE in Gastrointestinal Cancer: Project 3 - Inhibiting Oxidative Phosphorylation in Pancreatic Cancer |
Funding Source: | NIH |
Role: | Co-I |
ID: | P50CA221707 |
Date: | 2019 - 2022 |
Title: | Multiparametric image processing for risk stratification and early detection of hepatocelllar carcinoma |
Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
Role: | PI |
Date: | 2019 - 2023 |
Title: | Early Detection of Pancreatic Cancer by Quantifying Tumor-Derived Exosomes in Blood |
Funding Source: | Department of Defense / Arizona State University |
Role: | Co-I |
ID: | GRANT12715628 |
Date: | 2019 - 2023 |
Title: | Awakening Pancreas Cancer Responsiveness to Immunotherapy by Combined Tumor-Stromal Targeting |
Funding Source: | Department of Defense/ Washington State University |
Role: | Co-I |
Date: | 2019 - 2026 |
Title: | STRATEGIC ALLIANCE: Characterization of pancreatic ductal adenocarcinoma (PDAC) subtypes with high resolution DECT |
Funding Source: | Siemens Medical Solutions USA, Inc |
Role: | PI |
ID: | PA14-0319 |
Date: | 2019 - 2022 |
Title: | Biophysical underpinnings of imageing-based subtypes of pancreatic cancer: toward precision oncology |
Funding Source: | NIH/NCI |
Role: | PI |
ID: | 1-R01-CA240813-01 |
Date: | 2019 - 2024 |
Title: | An Adaptive Phase I/II Dose Escalation Trial of Stereotactic Body Radiation Therapy with a Radiomodulating Agent GC4419 in Locally Advanced Pancreatic Cancer |
Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
Role: | Co-I |
Date: | 2018 - 2026 |
Title: | A Phase I Study of NBTXR3 activated by Radiotherapy for Locally Advanced or Borderline-Resectable Pancreatic Ductal Adenocarcinoma - 2019-1001 |
Funding Source: | Nanobiotix |
Role: | PI |
ID: | 2019-1001 |
Date: | 2018 - Present |
Title: | Circulating Biomarkers and Imaging for Early Detection of Pancreatic Cancer |
Funding Source: | NIH/NCI |
Role: | Co-I |
ID: | 5-U01-CA214263-03 |
Date: | 2018 - 2023 |
Title: | MD Anderson Cancer Center SPORE in Gastrointestinal Cancer |
Funding Source: | NIH/NCI |
Role: | Co-I |
Date: | 2018 - 2020 |
Title: | Cellular Landscape of Intrahepatic Cholangiocarcinoma |
Funding Source: | Khalifa foundation/Institute for Personalized Cancer Therapy |
Role: | PI |
Date: | 2018 - 2024 |
Title: | Optimization and Evaluation of Anatomical Models of Liver Radiation Response |
Funding Source: | NIH/NCI |
Role: | Co-I |
ID: | 5-R01-CA221971-03 |
Date: | 2018 - 2023 |
Title: | Measuring extracellular pH in pre-clinical tumor models with acidoCEST MRI |
Funding Source: | NIH/NCI |
Role: | Co-I |
Date: | 2018 - 2023 |
Title: | Translational applications in an animal model of pancreatic cystic neoplasm and cancer |
Funding Source: | NIH/NCI |
Role: | Co-I |
ID: | R01-CA218004-01A1 |
Date: | 2018 - 2023 |
Title: | Fellow and Resident Radiation Oncology iNtensive Training in Imaging and Informatics to Empower Research Careers (FRONTI2ER) |
Funding Source: | NIH/NIBIB |
Role: | Mentor |
ID: | 1R25EB025787 |
Date: | 2018 - 2022 |
Title: | Intercepting Pancreatic Cancer in High Risk Cohorts |
Funding Source: | AACR SU2 |
Role: | Co-I |
ID: | SU2C-AACR-DT25-17 |
Date: | 2017 - 2027 |
Title: | Early Detection of Hepatocellular Carcinoma |
Funding Source: | NIH |
Role: | Multiple Principle Investigator |
ID: | 2R01CA195524-06A1 |
Date: | 2016 - 2027 |
Title: | A Clinical Validation Center for Early Detection of Pancreatic Cancer |
Funding Source: | NIH/NCI |
Role: | Co-I |
ID: | U01CA200468 |
Date: | 2016 - 2019 |
Title: | Pancreatic Moonshot Flagship 3 |
Funding Source: | MD Anderson Cancer Center |
Role: | Co-I |
Date: | 2016 - 2021 |
Title: | Center for Immunotherapeutic Transport Oncophysics: Project 2 – Microenvironmental transport of immunotherapy in pancreatic cancer |
Funding Source: | NIH/NCI |
Role: | Co-Investigator and Co-Project 2 Leader |
ID: | 5 U54 CA21018102 |
Date: | 2016 - 2019 |
Title: | Quantitative image processing for early detection of pancreatic cancer |
Funding Source: | Project Purple Grant |
Role: | PI |
Date: | 2016 - 2019 |
Title: | Diagnostic markers of malignant progression in mucinous pancreatic cysts |
Funding Source: | PANCAN Translational Research Grant |
Role: | Co-I |
ID: | 16-65-SING |
Date: | 2016 - 2021 |
Title: | MRI-based investigations into the stromal, immunological, and metabolic properties of pancreatic cancer |
Funding Source: | General Electric and Center for Advanced Biomedical Imaging MI2 Grant |
Role: | Co-PI |
Date: | 2015 - 2021 |
Title: | Imaging and molecular correlates of progression in cystic neoplasms of the pancreas |
Funding Source: | NIH/NCI |
Role: | Co-I |
ID: | 5U01CA196403 |
Date: | 2015 - 2016 |
Title: | Pancreas Moonshot Flagship 1: Project PANC – Drug and Biomarker Discovery |
Funding Source: | Drug and Biomarker Discovery, MD Anderson Cancer Center |
Role: | Co-I |
Date: | 2015 - 2017 |
Title: | An imaging-based stromal signature of pancreatic cancer |
Funding Source: | MD Anderson Cancer Center |
Role: | PI |
ID: | Institutional Research Grant |
Date: | 2015 - 2022 |
Title: | Quantitative EASL as a biomarker of response to radiation in pancreatic and hepatobiliary cancers |
Funding Source: | Philips Healthcare Sponsored Research Agreement |
Role: | PI |
Date: | 2014 - 2015 |
Title: | An integrated radiomic platform for radiological and pathological correlations |
Funding Source: | Center for Radiation Oncology Research, MD Anderson Cancer Center |
Role: | PI |
ID: | Institutional Seed Grant |
Date: | 2014 - 2019 |
Title: | Improving the Clinical Effectiveness and Understanding of the Biophysical Basis of Proton Therapy: Project 1 - Randomized Clinical Trials to Exploit the Physical and Biophysical Properties of Protons including Reduction in Dose Bath with Protons |
Funding Source: | NIH/NCI |
Role: | Co-I |
ID: | 5U19CA021239-38 |
Date: | 2014 - 2015 |
Title: | Clinical significance and histopathological basis of CT-derived transport properties of pancreatic cancer and colorectal liver metastases |
Funding Source: | NCI PSOC |
Role: | Co-I |
ID: | Center for Transport Oncophysics |
Date: | 2014 - 2017 |
Title: | Changes in Mass Transport as a Biomarker of Response in Pancreatic Cancer |
Funding Source: | PANCAN-AACR |
Role: | PI |
ID: | 14-20-25-KOAY |
Date: | 2014 - 2016 |
Title: | Predicting gemcitabine delivery in human pancreatic cancer with mass transport |
Funding Source: | Radiological Society of North America (RSNA) |
Role: | PI |
ID: | RSD1429 |
Date: | 2009 - 2014 |
Title: | Center for Transport Oncophysics - Project 3: Genomic Correlates of Mass Transport Differentials |
Funding Source: | NIH/NCI |
Role: | Co-I |
ID: | 5 U54 CA143837 |
Patient Reviews
CV information above last modified May 16, 2025